data_2ly3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ly3 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.455 ' CD2' HD11 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . 0.402 ' HA3' HG11 ' 1' ' 98' ' ' VAL . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.415 ' CB ' ' CD2' ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.57 ' O ' HG13 ' 1' ' 46' ' ' ILE . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.449 ' HA ' HD11 ' 1' ' 46' ' ' ILE . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.57 HG13 ' O ' ' 1' ' 42' ' ' GLN . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.414 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . 0.425 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' 1' ' 81' ' ' PHE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.5 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.471 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.557 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' 1' ' 61' ' ' VAL . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.435 ' CG ' HG21 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.434 ' HB3' HG22 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' 1' ' 84' ' ' ARG . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' 1' ' 83' ' ' LEU . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.4 ' CG1' ' NH1' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . 0.415 ' N ' HG23 ' 1' ' 98' ' ' VAL . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.548 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.828 0.347 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.586 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.423 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.419 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' 1' ' 65' ' ' ILE . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' 1' ' 47' ' ' GLU . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.422 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' 1' ' 46' ' ' ILE . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' CZ ' ' 1' ' 81' ' ' PHE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.412 ' CG1' ' CG2' ' 1' ' 98' ' ' VAL . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' 1' ' 58' ' ' ARG . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.425 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' 1' ' 89' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.5 OUTLIER -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.502 HD12 HG23 ' 1' ' 95' ' ' ILE . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.452 HD12 ' CE1' ' 1' ' 74' ' ' TYR . 3.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.853 0.358 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.418 ' CD2' ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' 1' ' 69' ' ' LEU . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.48 ' CD1' ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.425 ' NE2' ' HA3' ' 1' ' 68' ' ' GLY . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.433 ' HA ' ' CD1' ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.463 HG21 HD11 ' 1' ' 46' ' ' ILE . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.477 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' 1' ' 48' ' ' SER . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.436 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.446 HG12 ' CZ ' ' 1' ' 81' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' 1' ' 68' ' ' GLY . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.499 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.423 HG23 ' CZ ' ' 1' ' 81' ' ' PHE . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' 1' ' 61' ' ' VAL . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.504 ' HD3' HG11 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' 1' ' 84' ' ' ARG . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' 1' ' 87' ' ' PRO . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' 1' ' 74' ' ' TYR . 6.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.807 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' 1' ' 95' ' ' ILE . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . 0.413 ' CG1' HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . 0.413 HD12 ' CG1' ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.61 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 1.1 t30 -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.484 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' 1' ' 46' ' ' ILE . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . 0.432 HG23 ' O ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.484 HG13 ' O ' ' 1' ' 42' ' ' GLN . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.449 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' 1' ' 81' ' ' PHE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.61 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.701 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.414 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.552 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' 1' ' 81' ' ' PHE . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.404 ' CA ' HD22 ' 1' ' 94' ' ' LEU . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.601 ' HD3' HG13 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.411 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.524 ' CG ' ' HA ' ' 1' ' 85' ' ' PRO . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.601 HG13 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' 1' ' 74' ' ' TYR . 8.6 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.601 ' CD1' HD23 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.412 ' CB ' ' CD1' ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.403 ' HB3' ' CB ' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.441 HG22 ' N ' ' 1' ' 47' ' ' GLU . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.435 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' 1' ' 47' ' ' GLU . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' 1' ' 81' ' ' PHE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' 1' ' 79' ' ' ILE . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.601 HD23 ' CD1' ' 1' ' 35' ' ' LEU . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' 1' ' 69' ' ' LEU . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.785 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.46 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.585 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.415 HD13 ' HB ' ' 1' ' 65' ' ' ILE . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' 1' ' 61' ' ' VAL . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' 1' ' 94' ' ' LEU . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.421 ' C ' ' CD ' ' 1' ' 86' ' ' PRO . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.455 HD23 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.455 ' N ' HD23 ' 1' ' 94' ' ' LEU . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' 1' ' 81' ' ' PHE . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.785 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.423 ' CB ' ' HD3' ' 1' ' 91' ' ' ARG . 57.3 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . 0.448 HD23 ' CG1' ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.616 ' CD1' ' CE1' ' 1' ' 74' ' ' TYR . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.43 ' CB ' ' CD2' ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.485 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.0 OUTLIER -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' 1' ' 40' ' ' ARG . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.485 HG13 ' O ' ' 1' ' 42' ' ' GLN . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.465 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . 0.46 ' NH2' HD22 ' 1' ' 94' ' ' LEU . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' 1' ' 81' ' ' PHE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' 1' ' 69' ' ' LEU . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CG ' ' 1' ' 77' ' ' PRO . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.709 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.435 ' HB3' HD22 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.433 ' C ' ' CD ' ' 1' ' 86' ' ' PRO . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . 0.402 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.423 ' HD3' ' CB ' ' 1' ' 23' ' ' ASN . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 1.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.46 HD22 ' NH2' ' 1' ' 58' ' ' ARG . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.451 ' N ' HD21 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.448 ' CG1' HD23 ' 1' ' 31' ' ' LEU . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.593 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.548 ' CD2' ' HB2' ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' CG2' ' CD2' ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.491 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.4 OUTLIER -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.491 HG13 ' O ' ' 1' ' 42' ' ' GLN . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.457 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.412 HG11 HD23 ' 1' ' 26' ' ' LEU . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' 1' ' 69' ' ' LEU . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' 1' ' 65' ' ' ILE . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.548 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . 0.41 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.491 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.548 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' 1' ' 83' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . . . . . . . . . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.544 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.43 HD12 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.404 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 4.7 m120 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . 0.411 HD23 HD23 ' 1' ' 69' ' ' LEU . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.538 ' CD1' HD22 ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . 0.403 ' HA ' HD11 ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' 1' ' 72' ' ' LEU . 1.4 t30 -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.433 HG22 HD21 ' 1' ' 69' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.432 ' O ' HG12 ' 1' ' 46' ' ' ILE . 0.1 OUTLIER -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.476 HG23 ' CZ ' ' 1' ' 57' ' ' PHE . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.445 ' O ' HD11 ' 1' ' 65' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.445 HD11 ' O ' ' 1' ' 61' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.557 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.456 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.543 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.42 ' HA ' HD21 ' 1' ' 94' ' ' LEU . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.501 ' HG2' ' CG1' ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.404 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.501 ' CG1' ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.401 ' O ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' 1' ' 79' ' ' ILE . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.527 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.435 HD13 ' HA3' ' 1' ' 73' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . 0.421 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.55 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.422 ' HB2' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.507 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.5 OUTLIER -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' 1' ' 40' ' ' ARG . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . 0.42 HG22 ' O ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.507 HG13 ' O ' ' 1' ' 42' ' ' GLN . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.461 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' 1' ' 69' ' ' LEU . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.55 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' 1' ' 68' ' ' GLY . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.653 ' HB3' ' CG ' ' 1' ' 77' ' ' PRO . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.653 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.404 ' CG1' ' CG2' ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.423 ' CD2' ' HG2' ' 1' ' 58' ' ' ARG . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' 1' ' 84' ' ' ARG . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.406 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' 1' ' 84' ' ' ARG . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.584 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.416 ' CD1' ' HA3' ' 1' ' 73' ' ' GLY . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 30' ' ' GLY . . . . . 0.4 ' O ' ' CG1' ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 31' ' ' LEU . . . . . 0.403 HD22 HD23 ' 1' ' 69' ' ' LEU . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 34' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 35' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' 1' ' 69' ' ' LEU . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 37' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 38' ' ' ASN . . . . . 0.442 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 42' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' 1' ' 39' ' ' VAL . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 46' ' ' ILE . . . . . 0.449 HG23 ' CZ ' ' 1' ' 57' ' ' PHE . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 47' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 48' ' ' SER . . . . . 0.529 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 49' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 50' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 57' ' ' PHE . . . . . 0.449 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 61' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' 1' ' 69' ' ' LEU . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 69' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' 1' ' 35' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 70' ' ' LYS . . . . . 0.717 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 72' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 74' ' ' TYR . . . . . 0.717 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 76' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 79' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' 1' ' 81' ' ' PHE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 81' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 83' ' ' LEU . . . . . 0.405 ' CA ' HD22 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 84' ' ' ARG . . . . . 0.588 ' HG2' HG11 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 85' ' ' PRO . . . . . 0.543 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 86' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 87' ' ' PRO . . . . . 0.45 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 93' ' ' VAL . . . . . 0.588 HG11 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 94' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 97' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' 1' 1 ' 98' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' 1' ' 69' ' ' LEU . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 100' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' 1' 1 ' 103' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' 1' ' 74' ' ' TYR . 4.9 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.8 OUTLIER -71.24 97.24 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.455 ' CD2' HD11 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . 0.402 ' HA3' HG11 ' 1' ' 98' ' ' VAL . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . 0.415 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . 0.512 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.512 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.415 ' CB ' ' CD2' ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.406 ' CG2' ' CD2' ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.57 ' O ' HG13 ' 1' ' 46' ' ' ILE . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.449 ' HA ' HD11 ' 1' ' 46' ' ' ILE . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.57 HG13 ' O ' ' 1' ' 42' ' ' GLN . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.492 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.414 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.492 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . 0.425 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.453 HG13 ' CE1' ' 1' ' 81' ' ' PHE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.435 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.5 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.616 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.565 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.616 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.471 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.557 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.465 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.453 ' CE1' HG13 ' 1' ' 61' ' ' VAL . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.422 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.435 ' CG ' HG21 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.434 ' HB3' HG22 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.433 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' 1' ' 84' ' ' ARG . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' 1' ' 83' ' ' LEU . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.4 ' CG1' ' NH1' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.441 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . 0.415 ' N ' HG23 ' 1' ' 98' ' ' VAL . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.548 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.437 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp -140.95 147.63 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.61 134.89 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 32.0 m170 60.6 79.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -88.11 -42.75 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 67.95 -70.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -146.72 178.97 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 60.52 91.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 p80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.913 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.838 0.351 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -111.1 48.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . 0.513 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.586 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.423 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.419 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' 1' ' 65' ' ' ILE . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.452 ' CG2' ' N ' ' 1' ' 47' ' ' GLU . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.549 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.422 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.549 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.424 ' CZ ' HG21 ' 1' ' 46' ' ' ILE . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.415 ' HB ' ' CZ ' ' 1' ' 81' ' ' PHE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.433 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.471 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.586 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.581 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.695 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.581 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.412 ' CG1' ' CG2' ' 1' ' 98' ' ' VAL . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.447 ' CD2' ' HG2' ' 1' ' 58' ' ' ARG . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.425 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.442 ' HB3' HG21 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . 0.462 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' 1' ' 89' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.421 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.5 OUTLIER -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.442 HG21 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.502 HD12 HG23 ' 1' ' 95' ' ' ILE . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.426 HG21 ' CD1' ' 1' ' 69' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.452 HD12 ' CE1' ' 1' ' 74' ' ' TYR . 3.5 tp -140.74 136.8 32.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -99.22 110.1 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -96.49 -32.82 12.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -128.32 31.33 5.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.45 158.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.7 119.67 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.9 -177.59 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.926 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.417 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 -102.99 45.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.418 ' CD2' ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . 0.401 ' CG1' HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . 0.416 ' CD2' HD21 ' 1' ' 69' ' ' LEU . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.48 ' CD1' ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.425 ' NE2' ' HA3' ' 1' ' 68' ' ' GLY . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.433 ' HA ' ' CD1' ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.463 HG21 HD11 ' 1' ' 46' ' ' ILE . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.499 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.477 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.477 ' H ' ' C ' ' 1' ' 48' ' ' SER . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.436 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.446 HG12 ' CZ ' ' 1' ' 81' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.408 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.422 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.578 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' 1' ' 68' ' ' GLY . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.578 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.499 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.554 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.423 HG23 ' CZ ' ' 1' ' 81' ' ' PHE . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.446 ' CZ ' HG12 ' 1' ' 61' ' ' VAL . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.504 ' HD3' HG11 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' 1' ' 84' ' ' ARG . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . 0.403 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.403 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.417 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.424 ' N ' ' HG3' ' 1' ' 87' ' ' PRO . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.504 HG11 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.412 ' CD2' ' HB3' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.418 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.554 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.434 HD12 ' CZ ' ' 1' ' 74' ' ' TYR . 6.6 tp -140.94 126.35 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.89 110.14 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -147.59 157.92 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -150.06 166.7 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 8.5 m80 60.14 84.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -71.31 86.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -92.05 153.55 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.847 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.414 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 58.29 79.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.406 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . 0.402 ' HB2' ' HA ' ' 1' ' 95' ' ' ILE . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . 0.413 ' CG1' HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . 0.413 HD12 ' CG1' ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . 0.425 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.61 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.429 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 1.1 t30 -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.484 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.413 ' HA ' ' CD1' ' 1' ' 46' ' ' ILE . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . 0.432 HG23 ' O ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.484 HG13 ' O ' ' 1' ' 42' ' ' GLN . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.475 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.449 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.475 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.457 ' HB ' ' CE2' ' 1' ' 81' ' ' PHE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.437 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.452 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.61 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.59 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.701 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.414 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.552 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.423 HG23 ' CE1' ' 1' ' 81' ' ' PHE . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.493 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.404 ' CA ' HD22 ' 1' ' 94' ' ' LEU . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.601 ' HD3' HG13 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.411 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . 0.404 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.404 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.414 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.524 ' CG ' ' HA ' ' 1' ' 85' ' ' PRO . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.601 HG13 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.493 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.416 HG23 ' CD1' ' 1' ' 69' ' ' LEU . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.621 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.437 HD11 ' CE1' ' 1' ' 74' ' ' TYR . 8.6 tp -132.26 129.62 39.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -75.62 142.32 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 99.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -148.6 -47.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -138.65 124.49 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -128.88 -179.38 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -80.26 84.47 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.904 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -79.01 75.86 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.601 ' CD1' HD23 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.412 ' CB ' ' CD1' ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.403 ' HB3' ' CB ' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.441 HG22 ' N ' ' 1' ' 47' ' ' GLU . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.634 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.435 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.634 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.429 ' CE2' ' HG2' ' 1' ' 47' ' ' GLU . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.448 HG12 ' CE1' ' 1' ' 81' ' ' PHE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . 0.403 ' CB ' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.415 ' HB ' HD13 ' 1' ' 79' ' ' ILE . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.485 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.601 HD23 ' CD1' ' 1' ' 35' ' ' LEU . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.689 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.499 HD13 ' HA ' ' 1' ' 69' ' ' LEU . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.785 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.46 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.585 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.415 HD13 ' HB ' ' 1' ' 65' ' ' ILE . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.448 ' CE1' HG12 ' 1' ' 61' ' ' VAL . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.401 ' HA ' ' HA ' ' 1' ' 94' ' ' LEU . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.421 ' C ' ' CD ' ' 1' ' 86' ' ' PRO . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.435 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.455 HD23 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.455 ' N ' HD23 ' 1' ' 94' ' ' LEU . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . 0.413 ' HB1' ' CE1' ' 1' ' 81' ' ' PHE . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.419 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.785 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.466 ' CD1' ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp -140.95 132.13 26.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.41 153.53 22.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -112.11 -177.89 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.75 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -132.95 115.71 15.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -97.94 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.57 94.29 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.869 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.423 ' CB ' ' HD3' ' 1' ' 91' ' ' ARG . 57.3 m-80 -105.13 47.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.422 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . 0.413 ' CG1' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . 0.448 HD23 ' CG1' ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . 0.402 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.616 ' CD1' ' CE1' ' 1' ' 74' ' ' TYR . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.405 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.43 ' CB ' ' CD2' ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . 0.46 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.485 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.0 OUTLIER -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.46 ' HB2' ' O ' ' 1' ' 40' ' ' ARG . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.485 HG13 ' O ' ' 1' ' 42' ' ' GLN . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.465 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.476 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.418 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . 0.46 ' NH2' HD22 ' 1' ' 94' ' ' LEU . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.432 ' HB ' ' CE2' ' 1' ' 81' ' ' PHE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.498 ' O ' ' N ' ' 1' ' 69' ' ' LEU . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.425 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.522 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' 1' ' 74' ' ' TYR . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.701 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . 0.62 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.709 ' HB3' ' CG ' ' 1' ' 77' ' ' PRO . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.709 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . . . . . . . . . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.435 ' HB3' HD22 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.433 ' C ' ' CD ' ' 1' ' 86' ' ' PRO . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.453 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . 0.402 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . 0.402 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.423 ' HD3' ' CB ' ' 1' ' 23' ' ' ASN . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.493 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 1.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.46 HD22 ' NH2' ' 1' ' 58' ' ' ARG . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.451 ' N ' HD21 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.448 ' CG1' HD23 ' 1' ' 31' ' ' LEU . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.593 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.62 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp -140.96 140.08 34.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -61.13 170.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -166.68 145.8 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -100.26 -37.64 8.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -136.21 159.82 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -150.35 106.7 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.18 173.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 29.8 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.903 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 60.71 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.452 ' CD2' ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.548 ' CD2' ' HB2' ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.403 ' CG2' ' CD2' ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.491 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.4 OUTLIER -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.491 HG13 ' O ' ' 1' ' 42' ' ' GLN . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.504 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.457 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.504 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.425 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.412 HG11 HD23 ' 1' ' 26' ' ' LEU . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.462 ' O ' ' N ' ' 1' ' 69' ' ' LEU . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.449 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.462 ' N ' ' O ' ' 1' ' 65' ' ' ILE . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.58 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.548 ' HB2' ' CD2' ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.58 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . 0.41 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.491 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.548 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.479 ' HA ' HD21 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.425 ' HA ' ' HD2' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.419 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.451 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.419 ' CG1' ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.479 HD21 ' HA ' ' 1' ' 83' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . . . . . . . . . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.4 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.544 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.43 HD12 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp -140.98 148.73 40.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.75 122.1 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -87.24 152.73 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -100.05 28.14 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.48 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.55 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -92.95 179.61 5.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.404 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 4.7 m120 -140.03 80.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . 0.411 HD23 HD23 ' 1' ' 69' ' ' LEU . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.538 ' CD1' HD22 ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . 0.403 ' HA ' HD11 ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.432 ' HB2' HD11 ' 1' ' 72' ' ' LEU . 1.4 t30 -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.433 HG22 HD21 ' 1' ' 69' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.432 ' O ' HG12 ' 1' ' 46' ' ' ILE . 0.1 OUTLIER -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.476 HG23 ' CZ ' ' 1' ' 57' ' ' PHE . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.548 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.548 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.476 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.445 ' O ' HD11 ' 1' ' 65' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.445 HD11 ' O ' ' 1' ' 61' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.557 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.585 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . 0.435 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.585 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.456 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.543 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.425 ' HA ' ' O ' ' 1' ' 97' ' ' LYS . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.434 ' HB3' ' CD2' ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.42 ' HA ' HD21 ' 1' ' 94' ' ' LEU . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.501 ' HG2' ' CG1' ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.438 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.404 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . 0.519 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.501 ' CG1' ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.434 ' CD2' ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.401 ' O ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.406 ' CG2' ' CG1' ' 1' ' 79' ' ' ILE . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.527 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.435 HD13 ' HA3' ' 1' ' 73' ' ' GLY . 0.2 OUTLIER -141.04 114.17 8.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -100.32 129.2 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -78.6 168.6 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -165.19 100.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -95.64 120.74 36.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.66 35.7 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -132.85 161.15 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.869 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.786 0.326 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.406 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER -153.88 85.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . 0.421 ' HB3' ' CD1' ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . . . . . . . . . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . 0.413 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.55 ' CD1' HD21 ' 1' ' 69' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.413 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.422 ' HB2' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.507 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.5 OUTLIER -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' 1' ' 40' ' ' ARG . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . 0.42 HG22 ' O ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.507 HG13 ' O ' ' 1' ' 42' ' ' GLN . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.496 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.461 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.496 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' 1' ' 47' ' ' GLU . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . 0.423 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.412 ' O ' ' HB2' ' 1' ' 69' ' ' LEU . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.55 HD21 ' CD1' ' 1' ' 35' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.632 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' 1' ' 68' ' ' GLY . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . 0.416 ' HA3' ' CD1' ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.653 ' HB3' ' CG ' ' 1' ' 77' ' ' PRO . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.653 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.404 ' CG1' ' CG2' ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.423 ' CD2' ' HG2' ' 1' ' 58' ' ' ARG . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . . . . . . . . . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' 1' ' 84' ' ' ARG . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.406 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.46 ' O ' ' N ' ' 1' ' 84' ' ' ARG . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.428 ' CG2' ' CB ' ' 1' ' 77' ' ' PRO . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.584 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.416 ' CD1' ' HA3' ' 1' ' 73' ' ' GLY . 0.2 OUTLIER -141.01 107.23 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -87.29 142.14 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.09 -165.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 11.4 t60 67.42 108.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -59.72 144.24 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.85 37.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -170.09 177.56 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 7.3 m170 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.881 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 -147.85 80.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 26' ' ' LEU . . . . . . . . . . . . . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 28' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 30' ' ' GLY . . . . . 0.4 ' O ' ' CG1' ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 31' ' ' LEU . . . . . 0.403 HD22 HD23 ' 1' ' 69' ' ' LEU . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 34' ' ' GLN . . . . . 0.484 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 35' ' ' LEU . . . . . 0.578 ' CD1' HD22 ' 1' ' 69' ' ' LEU . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 37' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 38' ' ' ASN . . . . . 0.442 ' HB2' HD13 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 39' ' ' VAL . . . . . 0.421 ' HA ' ' OE1' ' 1' ' 42' ' ' GLN . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 42' ' ' GLN . . . . . 0.421 ' OE1' ' HA ' ' 1' ' 39' ' ' VAL . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 43' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 45' ' ' THR . . . . . . . . . . . . . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 46' ' ' ILE . . . . . 0.449 HG23 ' CZ ' ' 1' ' 57' ' ' PHE . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 47' ' ' GLU . . . . . 0.478 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 48' ' ' SER . . . . . 0.529 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 49' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 50' ' ' GLU . . . . . 0.529 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 ' CG1' ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 57' ' ' PHE . . . . . 0.449 ' CZ ' HG23 ' 1' ' 46' ' ' ILE . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 61' ' ' VAL . . . . . 0.415 ' CG1' HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 65' ' ' ILE . . . . . 0.414 ' O ' ' HG ' ' 1' ' 69' ' ' LEU . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 68' ' ' GLY . . . . . 0.425 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 69' ' ' LEU . . . . . 0.578 HD22 ' CD1' ' 1' ' 35' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 70' ' ' LYS . . . . . 0.717 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 72' ' ' LEU . . . . . 0.512 HD11 ' HA ' ' 1' ' 69' ' ' LEU . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 74' ' ' TYR . . . . . 0.717 ' O ' ' HA ' ' 1' ' 70' ' ' LYS . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 76' ' ' GLN . . . . . 0.435 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 79' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' 1' ' 81' ' ' PHE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 81' ' ' PHE . . . . . 0.425 ' CD1' HD13 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 83' ' ' LEU . . . . . 0.405 ' CA ' HD22 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 84' ' ' ARG . . . . . 0.588 ' HG2' HG11 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 85' ' ' PRO . . . . . 0.543 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 86' ' ' PRO . . . . . 0.543 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 87' ' ' PRO . . . . . 0.45 ' CD ' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 93' ' ' VAL . . . . . 0.588 HG11 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 94' ' ' LEU . . . . . 0.425 HD13 ' CD1' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 95' ' ' ILE . . . . . . . . . . . . . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 97' ' ' LYS . . . . . 0.404 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' 1' 1 ' 98' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' 1' ' 69' ' ' LEU . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 100' ' ' PRO . . . . . 0.624 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 103' ' ' LEU . . . . . 0.439 HD11 ' CE1' ' 1' ' 74' ' ' TYR . 4.9 tp -140.7 144.73 35.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 142.15 51.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.42 153.84 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -66.31 -169.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 151.25 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -102.86 -48.99 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -60.78 164.32 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.463 HG11 ' O ' ' 1' ' 48' ' ' SER . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.642 HD22 HD12 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 1.009 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.579 ' O ' HG12 ' 1' ' 98' ' ' VAL . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.766 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . 0.512 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.998 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.514 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.608 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.879 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 1.009 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.521 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.838 HD13 HG13 ' 1' ' 61' ' ' VAL . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.544 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.463 ' O ' HG11 ' 1' ' 24' ' ' VAL . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' 1' ' 51' ' ' VAL . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.605 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.867 ' O ' HD12 ' 1' ' 65' ' ' ILE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.867 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.702 HD23 HD21 ' 1' ' 72' ' ' LEU . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.998 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.881 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.487 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.572 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.533 HG22 ' CE1' ' 1' ' 81' ' ' PHE . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.729 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.572 HD12 ' O ' ' 1' ' 93' ' ' VAL . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.916 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.593 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' 1' ' 23' ' ' ASN . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.766 HG11 ' CD2' ' 1' ' 31' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.557 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.582 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.9 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.828 0.347 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.745 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.722 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . 0.47 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.853 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.755 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.684 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.755 HG23 ' O ' ' 1' ' 35' ' ' LEU . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.559 ' HA ' HG22 ' 1' ' 45' ' ' THR . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.559 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.851 HG13 HG13 ' 1' ' 61' ' ' VAL . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' N ' HG22 ' 1' ' 46' ' ' ILE . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.485 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.598 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.659 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . 0.456 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.851 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.996 HD13 HG21 ' 1' ' 79' ' ' ILE . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.715 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.755 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.451 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.996 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.536 HD12 ' O ' ' 1' ' 93' ' ' VAL . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.682 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' 1' ' 88' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.418 ' C ' ' HG3' ' 1' ' 87' ' ' PRO . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.745 ' O ' HG12 ' 1' ' 24' ' ' VAL . 4.3 mt-30 -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.452 ' N ' HD22 ' 1' ' 94' ' ' LEU . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.853 HG11 HD21 ' 1' ' 31' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.644 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 3.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.853 0.358 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.616 HG12 ' H ' ' 1' ' 92' ' ' GLN . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 0.478 HG13 HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.584 ' O ' HG12 ' 1' ' 98' ' ' VAL . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.693 HD13 HG21 ' 1' ' 39' ' ' VAL . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.802 HG23 ' O ' ' 1' ' 35' ' ' LEU . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.445 ' O ' HG13 ' 1' ' 46' ' ' ILE . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.571 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.444 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.4 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.58 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.795 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.795 HG23 ' O ' ' 1' ' 57' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.861 HD13 HG21 ' 1' ' 79' ' ' ILE . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' 1' ' 77' ' ' PRO . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.763 ' HB2' HD22 ' 1' ' 35' ' ' LEU . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.555 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . 0.776 HG22 ' OE2' ' 1' ' 80' ' ' GLU . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.864 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' 1' ' 78' ' ' THR . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.543 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' 1' ' 84' ' ' ARG . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.534 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.996 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.616 ' H ' HG12 ' 1' ' 24' ' ' VAL . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.996 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.401 ' N ' HG22 ' 1' ' 95' ' ' ILE . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.864 HG23 HG13 ' 1' ' 79' ' ' ILE . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.555 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.807 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.511 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 1.085 HD11 HD13 ' 1' ' 94' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 1.038 HG13 HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.642 ' O ' HG12 ' 1' ' 98' ' ' VAL . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . 0.484 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 1.038 HD12 HG13 ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.837 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.733 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.837 HG23 ' O ' ' 1' ' 35' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.614 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.614 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.777 HD12 HD23 ' 1' ' 26' ' ' LEU . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.55 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.568 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.75 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.803 ' O ' HD12 ' 1' ' 65' ' ' ILE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.874 HD13 HG21 ' 1' ' 79' ' ' ILE . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.429 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.877 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.812 HD21 ' NE2' ' 1' ' 92' ' ' GLN . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.602 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' 1' ' 92' ' ' GLN . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.521 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.812 ' NE2' HD21 ' 1' ' 83' ' ' LEU . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.602 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 1.085 HD13 HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.503 HD11 ' NH2' ' 1' ' 84' ' ' ARG . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' 1' ' 26' ' ' LEU . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.877 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 8.6 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.547 HG12 ' O ' ' 1' ' 92' ' ' GLN . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 0.759 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.718 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . 0.411 ' O ' HD23 ' 1' ' 31' ' ' LEU . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' 1' ' 39' ' ' VAL . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.722 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . 0.913 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.859 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.913 HG23 ' O ' ' 1' ' 41' ' ' ALA . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 HG13 HG13 ' 1' ' 61' ' ' VAL . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.405 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.48 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.505 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.942 ' O ' HD12 ' 1' ' 65' ' ' ILE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . 0.859 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.942 HD12 ' O ' ' 1' ' 61' ' ' VAL . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.713 ' CD1' HG21 ' 1' ' 98' ' ' VAL . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.82 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.478 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.591 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.764 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' 1' ' 96' ' ' ALA . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.513 HD12 ' O ' ' 1' ' 93' ' ' VAL . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.849 ' HG2' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.74 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.547 ' O ' HG12 ' 1' ' 24' ' ' VAL . 17.4 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.849 HG23 ' HG2' ' 1' ' 84' ' ' ARG . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.507 HD22 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.553 HD12 ' HE ' ' 1' ' 84' ' ' ARG . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.764 HG23 HG13 ' 1' ' 79' ' ' ILE . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.82 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.707 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 18.4 m120 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.785 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 1.095 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.436 ' O ' HG12 ' 1' ' 98' ' ' VAL . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.717 HD21 HG11 ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 1.048 HD22 HD13 ' 1' ' 72' ' ' LEU . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.484 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.571 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.511 ' O ' HG13 ' 1' ' 46' ' ' ILE . 2.8 mp0 -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 1.095 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.79 HD12 HD23 ' 1' ' 26' ' ' LEU . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.555 ' N ' HG22 ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.443 ' HB2' HG23 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.564 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.726 ' O ' HG23 ' 1' ' 61' ' ' VAL . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.852 ' O ' HD12 ' 1' ' 65' ' ' ILE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.852 HD12 ' O ' ' 1' ' 61' ' ' VAL . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.803 HD23 HD11 ' 1' ' 72' ' ' LEU . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 1.048 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' 1' ' 35' ' ' LEU . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.727 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.852 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.518 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.566 ' HE ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' 1' ' 91' ' ' ARG . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.785 ' O ' HG12 ' 1' ' 24' ' ' VAL . 6.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.603 ' N ' HD22 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' 1' ' 26' ' ' LEU . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.852 HG23 HG13 ' 1' ' 79' ' ' ILE . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.606 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.975 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 1.021 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.961 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.45 ' O ' ' NE2' ' 1' ' 42' ' ' GLN . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.763 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.516 ' O ' HG13 ' 1' ' 46' ' ' ILE . 2.8 mp0 -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 1.021 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.975 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.567 ' N ' HG22 ' 1' ' 46' ' ' ILE . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.603 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . 0.409 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.62 HG22 HG23 ' 1' ' 46' ' ' ILE . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.853 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.961 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.874 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.504 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.56 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.853 HG21 HD13 ' 1' ' 65' ' ' ILE . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.905 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.82 HD12 HD11 ' 1' ' 26' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.747 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.577 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 4.7 m120 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.568 HG12 ' O ' ' 1' ' 92' ' ' GLN . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.782 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.498 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.871 HD21 HG11 ' 1' ' 98' ' ' VAL . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.907 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . 0.417 ' N ' ' HB3' ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.731 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.907 HG23 ' O ' ' 1' ' 35' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . 0.908 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.437 ' O ' HG12 ' 1' ' 46' ' ' ILE . 4.3 mp0 -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.908 HG23 ' O ' ' 1' ' 41' ' ' ALA . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.722 HG13 HG13 ' 1' ' 61' ' ' VAL . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.47 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.486 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.577 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.461 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.722 HG13 HG13 ' 1' ' 46' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.564 HG13 HG13 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.857 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.781 ' CE2' HD12 ' 1' ' 35' ' ' LEU . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.867 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.726 HD11 ' OE1' ' 1' ' 92' ' ' GLN . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' 1' ' 92' ' ' GLN . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.456 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.726 ' OE1' HD11 ' 1' ' 83' ' ' LEU . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.602 ' N ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG11 HD21 ' 1' ' 31' ' ' LEU . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.528 ' HG3' ' CD2' ' 1' ' 74' ' ' TYR . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.647 HD12 ' C ' ' 1' ' 103' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.445 HG12 ' O ' ' 1' ' 92' ' ' GLN . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.769 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 1.031 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.567 ' O ' HG12 ' 1' ' 98' ' ' VAL . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . 0.456 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.706 HD21 HG11 ' 1' ' 98' ' ' VAL . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.7 ' HA ' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.718 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' 1' ' 45' ' ' THR . 2.4 mp0 -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 1.031 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.549 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.715 HG23 HG22 ' 1' ' 61' ' ' VAL . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.553 ' N ' HG22 ' 1' ' 46' ' ' ILE . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . 0.569 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.663 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.928 ' O ' HD12 ' 1' ' 65' ' ' ILE . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 0.928 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.718 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . 0.512 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.706 ' HE1' HD22 ' 1' ' 103' ' ' LEU . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.676 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 0.871 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.74 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.458 HD13 HD23 ' 1' ' 94' ' ' LEU . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . 0.445 ' O ' HG12 ' 1' ' 24' ' ' VAL . 33.4 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' 1' ' 82' ' ' ASP . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' 1' ' 26' ' ' LEU . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.589 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.706 HD22 ' HE1' ' 1' ' 74' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 24' ' ' VAL . . . . . 0.77 HG21 ' O ' ' 1' ' 48' ' ' SER . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 26' ' ' LEU . . . . . 0.899 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 27' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 28' ' ' VAL . . . . . 0.892 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 29' ' ' GLU . . . . . 0.856 ' O ' HG12 ' 1' ' 98' ' ' VAL . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 30' ' ' GLY . . . . . 0.466 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 31' ' ' LEU . . . . . 0.804 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 32' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 34' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 35' ' ' LEU . . . . . 0.726 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 37' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 38' ' ' ASN . . . . . 0.685 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 39' ' ' VAL . . . . . 0.726 HG23 ' O ' ' 1' ' 35' ' ' LEU . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 41' ' ' ALA . . . . . 0.935 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 43' ' ' LEU . . . . . 0.899 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 45' ' ' THR . . . . . 0.935 HG23 ' O ' ' 1' ' 41' ' ' ALA . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 46' ' ' ILE . . . . . 0.861 HG13 HG13 ' 1' ' 61' ' ' VAL . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 47' ' ' GLU . . . . . 0.537 ' O ' HG13 ' 1' ' 51' ' ' VAL . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 48' ' ' SER . . . . . 0.77 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 49' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 50' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 51' ' ' VAL . . . . . 0.537 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 53' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 57' ' ' PHE . . . . . 0.589 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 61' ' ' VAL . . . . . 0.861 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 65' ' ' ILE . . . . . 1.003 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 68' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 69' ' ' LEU . . . . . 0.685 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 70' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 72' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 76' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 77' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 79' ' ' ILE . . . . . 1.003 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 81' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 83' ' ' LEU . . . . . 0.722 ' HB2' HD23 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 84' ' ' ARG . . . . . 0.857 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 85' ' ' PRO . . . . . 0.563 ' CD ' ' HD3' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 86' ' ' PRO . . . . . 0.563 ' HD3' ' CD ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 87' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 88' ' ' LYS . . . . . 0.415 ' HD2' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' HD2' ' 1' ' 88' ' ' LYS . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 90' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 93' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 94' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 95' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 96' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 97' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' 1' 1 ' 98' ' ' VAL . . . . . 0.886 HG23 HG13 ' 1' ' 79' ' ' ILE . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 100' ' ' PRO . . . . . 0.653 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 4.9 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.6 OUTLIER -71.24 97.24 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.463 HG11 ' O ' ' 1' ' 48' ' ' SER . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.642 HD22 HD12 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 1.009 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.579 ' O ' HG12 ' 1' ' 98' ' ' VAL . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.766 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . 0.512 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.998 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.514 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.608 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.879 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 1.009 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.521 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.838 HD13 HG13 ' 1' ' 61' ' ' VAL . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.544 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.463 ' O ' HG11 ' 1' ' 24' ' ' VAL . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' 1' ' 51' ' ' VAL . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.605 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.867 ' O ' HD12 ' 1' ' 65' ' ' ILE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.867 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.702 HD23 HD21 ' 1' ' 72' ' ' LEU . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.998 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.881 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.487 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.572 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.533 HG22 ' CE1' ' 1' ' 81' ' ' PHE . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.729 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.572 HD12 ' O ' ' 1' ' 93' ' ' VAL . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.916 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.593 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' 1' ' 23' ' ' ASN . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.766 HG11 ' CD2' ' 1' ' 31' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.557 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.582 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.9 tp -140.95 147.63 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.61 134.89 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 32.0 m170 60.6 79.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -88.11 -42.75 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 67.95 -70.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -146.72 178.97 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 60.52 91.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 p80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.913 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.838 0.351 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -111.1 48.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.745 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.722 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . 0.47 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.853 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.755 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.684 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.755 HG23 ' O ' ' 1' ' 35' ' ' LEU . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.559 ' HA ' HG22 ' 1' ' 45' ' ' THR . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.559 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.851 HG13 HG13 ' 1' ' 61' ' ' VAL . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' N ' HG22 ' 1' ' 46' ' ' ILE . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.485 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.598 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.659 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . 0.456 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.851 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.996 HD13 HG21 ' 1' ' 79' ' ' ILE . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.715 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.755 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.451 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.996 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.536 HD12 ' O ' ' 1' ' 93' ' ' VAL . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.682 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' 1' ' 88' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.418 ' C ' ' HG3' ' 1' ' 87' ' ' PRO . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.745 ' O ' HG12 ' 1' ' 24' ' ' VAL . 4.3 mt-30 -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.452 ' N ' HD22 ' 1' ' 94' ' ' LEU . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.853 HG11 HD21 ' 1' ' 31' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.644 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 3.5 tp -140.74 136.8 32.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -99.22 110.1 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -96.49 -32.82 12.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 19.1 p-80 -128.32 31.33 5.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.45 158.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.7 119.67 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.9 -177.59 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.926 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 -102.99 45.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.616 HG12 ' H ' ' 1' ' 92' ' ' GLN . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 0.478 HG13 HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.584 ' O ' HG12 ' 1' ' 98' ' ' VAL . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.693 HD13 HG21 ' 1' ' 39' ' ' VAL . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.802 HG23 ' O ' ' 1' ' 35' ' ' LEU . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.445 ' O ' HG13 ' 1' ' 46' ' ' ILE . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.571 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.444 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.4 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.58 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.795 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.795 HG23 ' O ' ' 1' ' 57' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.861 HD13 HG21 ' 1' ' 79' ' ' ILE . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' 1' ' 77' ' ' PRO . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.763 ' HB2' HD22 ' 1' ' 35' ' ' LEU . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.555 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . 0.776 HG22 ' OE2' ' 1' ' 80' ' ' GLU . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.864 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' 1' ' 78' ' ' THR . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.543 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' 1' ' 84' ' ' ARG . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.534 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.996 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.616 ' H ' HG12 ' 1' ' 24' ' ' VAL . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.996 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.401 ' N ' HG22 ' 1' ' 95' ' ' ILE . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.864 HG23 HG13 ' 1' ' 79' ' ' ILE . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.555 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.6 tp -140.94 126.35 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.89 110.14 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -147.59 157.92 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -150.06 166.7 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 8.5 m80 60.14 84.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -71.31 86.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -92.05 153.55 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.847 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 58.29 79.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.511 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 1.085 HD11 HD13 ' 1' ' 94' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 1.038 HG13 HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.642 ' O ' HG12 ' 1' ' 98' ' ' VAL . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . 0.484 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 1.038 HD12 HG13 ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.837 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.733 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.837 HG23 ' O ' ' 1' ' 35' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.614 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.614 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.777 HD12 HD23 ' 1' ' 26' ' ' LEU . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.55 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.568 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.75 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.803 ' O ' HD12 ' 1' ' 65' ' ' ILE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.874 HD13 HG21 ' 1' ' 79' ' ' ILE . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.429 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.877 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.812 HD21 ' NE2' ' 1' ' 92' ' ' GLN . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.602 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' 1' ' 92' ' ' GLN . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.521 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.812 ' NE2' HD21 ' 1' ' 83' ' ' LEU . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.602 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 1.085 HD13 HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.503 HD11 ' NH2' ' 1' ' 84' ' ' ARG . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' 1' ' 26' ' ' LEU . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.877 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 8.6 tp -132.26 129.62 39.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -75.62 142.32 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 99.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -148.6 -47.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -138.65 124.49 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -128.88 -179.38 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -80.26 84.47 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.904 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' 1' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -79.01 75.86 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.547 HG12 ' O ' ' 1' ' 92' ' ' GLN . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 0.759 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.718 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . 0.411 ' O ' HD23 ' 1' ' 31' ' ' LEU . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' 1' ' 39' ' ' VAL . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.722 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . 0.913 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.859 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.913 HG23 ' O ' ' 1' ' 41' ' ' ALA . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 HG13 HG13 ' 1' ' 61' ' ' VAL . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.405 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' 1' ' 22' ' ' ALA . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.48 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.505 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.942 ' O ' HD12 ' 1' ' 65' ' ' ILE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . 0.859 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.942 HD12 ' O ' ' 1' ' 61' ' ' VAL . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.713 ' CD1' HG21 ' 1' ' 98' ' ' VAL . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.82 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.478 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.591 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.764 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' 1' ' 96' ' ' ALA . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.513 HD12 ' O ' ' 1' ' 93' ' ' VAL . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.849 ' HG2' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.74 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.547 ' O ' HG12 ' 1' ' 24' ' ' VAL . 17.4 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.849 HG23 ' HG2' ' 1' ' 84' ' ' ARG . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.507 HD22 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.553 HD12 ' HE ' ' 1' ' 84' ' ' ARG . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.764 HG23 HG13 ' 1' ' 79' ' ' ILE . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.82 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.707 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp -140.95 132.13 26.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.41 153.53 22.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -112.11 -177.89 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.75 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -132.95 115.71 15.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -97.94 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.57 94.29 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.869 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' 1' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 18.4 m120 -105.13 47.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.785 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 1.095 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.436 ' O ' HG12 ' 1' ' 98' ' ' VAL . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.717 HD21 HG11 ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 1.048 HD22 HD13 ' 1' ' 72' ' ' LEU . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.484 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.4 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.571 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.511 ' O ' HG13 ' 1' ' 46' ' ' ILE . 2.8 mp0 -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 1.095 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.79 HD12 HD23 ' 1' ' 26' ' ' LEU . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.555 ' N ' HG22 ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.443 ' HB2' HG23 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB2' ' 1' ' 22' ' ' ALA . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.564 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.726 ' O ' HG23 ' 1' ' 61' ' ' VAL . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.852 ' O ' HD12 ' 1' ' 65' ' ' ILE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.852 HD12 ' O ' ' 1' ' 61' ' ' VAL . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.803 HD23 HD11 ' 1' ' 72' ' ' LEU . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 1.048 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' 1' ' 35' ' ' LEU . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.727 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.852 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.518 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.566 ' HE ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' 1' ' 91' ' ' ARG . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.785 ' O ' HG12 ' 1' ' 24' ' ' VAL . 6.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.603 ' N ' HD22 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' 1' ' 26' ' ' LEU . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.852 HG23 HG13 ' 1' ' 79' ' ' ILE . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.606 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp -140.96 140.08 34.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -61.13 170.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -166.68 145.8 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -100.26 -37.64 8.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -136.21 159.82 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -150.35 106.7 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.18 173.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 29.8 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.903 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 60.71 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.975 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 1.021 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.961 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.45 ' O ' ' NE2' ' 1' ' 42' ' ' GLN . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.763 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.516 ' O ' HG13 ' 1' ' 46' ' ' ILE . 2.8 mp0 -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 1.021 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.975 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.567 ' N ' HG22 ' 1' ' 46' ' ' ILE . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.603 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . 0.409 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.62 HG22 HG23 ' 1' ' 46' ' ' ILE . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.853 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.961 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.874 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.504 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.56 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.853 HG21 HD13 ' 1' ' 65' ' ' ILE . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.905 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.82 HD12 HD11 ' 1' ' 26' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.747 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.577 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp -140.98 148.73 40.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.75 122.1 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -87.24 152.73 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -100.05 28.14 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.48 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.55 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -92.95 179.61 5.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 4.7 m120 -140.03 80.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.568 HG12 ' O ' ' 1' ' 92' ' ' GLN . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.782 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.498 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.871 HD21 HG11 ' 1' ' 98' ' ' VAL . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.907 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . 0.417 ' N ' ' HB3' ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.731 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.907 HG23 ' O ' ' 1' ' 35' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . 0.908 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.437 ' O ' HG12 ' 1' ' 46' ' ' ILE . 4.3 mp0 -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.908 HG23 ' O ' ' 1' ' 41' ' ' ALA . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.722 HG13 HG13 ' 1' ' 61' ' ' VAL . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.47 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.486 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.577 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.461 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.722 HG13 HG13 ' 1' ' 46' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.564 HG13 HG13 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.857 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.781 ' CE2' HD12 ' 1' ' 35' ' ' LEU . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.867 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.726 HD11 ' OE1' ' 1' ' 92' ' ' GLN . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' 1' ' 92' ' ' GLN . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.456 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.726 ' OE1' HD11 ' 1' ' 83' ' ' LEU . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.602 ' N ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG11 HD21 ' 1' ' 31' ' ' LEU . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.528 ' HG3' ' CD2' ' 1' ' 74' ' ' TYR . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD12 ' N ' ' 1' ' 104' ' ' GLU . 0.2 OUTLIER -141.04 114.17 8.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . 0.755 ' N ' HD12 ' 1' ' 103' ' ' LEU . 33.2 mt-10 -100.32 129.2 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -78.6 168.6 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -165.19 100.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -95.64 120.74 36.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.66 35.7 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -132.85 161.15 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.869 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . 0.428 ' HB3' ' HG3' ' 1' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.786 0.326 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER -153.88 85.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.445 HG12 ' O ' ' 1' ' 92' ' ' GLN . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.769 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 1.031 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.567 ' O ' HG12 ' 1' ' 98' ' ' VAL . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . 0.456 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.706 HD21 HG11 ' 1' ' 98' ' ' VAL . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.7 ' HA ' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.718 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' 1' ' 45' ' ' THR . 2.4 mp0 -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 1.031 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.549 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.715 HG23 HG22 ' 1' ' 61' ' ' VAL . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.553 ' N ' HG22 ' 1' ' 46' ' ' ILE . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . 0.569 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.663 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.928 ' O ' HD12 ' 1' ' 65' ' ' ILE . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 0.928 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.718 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . 0.512 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.706 ' HE1' HD22 ' 1' ' 103' ' ' LEU . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.676 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 0.871 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.74 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.458 HD13 HD23 ' 1' ' 94' ' ' LEU . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . 0.445 ' O ' HG12 ' 1' ' 24' ' ' VAL . 33.4 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' 1' ' 82' ' ' ASP . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' 1' ' 26' ' ' LEU . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.589 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.706 HD22 ' HE1' ' 1' ' 74' ' ' TYR . 0.2 OUTLIER -141.01 107.23 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . 0.608 ' N ' HD12 ' 1' ' 103' ' ' LEU . 1.9 pm0 -87.29 142.14 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.09 -165.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 11.4 t60 67.42 108.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -59.72 144.24 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.85 37.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -170.09 177.56 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.881 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 -147.85 80.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 24' ' ' VAL . . . . . 0.77 HG21 ' O ' ' 1' ' 48' ' ' SER . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 26' ' ' LEU . . . . . 0.899 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 27' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 28' ' ' VAL . . . . . 0.892 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 29' ' ' GLU . . . . . 0.856 ' O ' HG12 ' 1' ' 98' ' ' VAL . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 30' ' ' GLY . . . . . 0.466 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 31' ' ' LEU . . . . . 0.804 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 32' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 34' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 35' ' ' LEU . . . . . 0.726 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 37' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 38' ' ' ASN . . . . . 0.685 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 39' ' ' VAL . . . . . 0.726 HG23 ' O ' ' 1' ' 35' ' ' LEU . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 41' ' ' ALA . . . . . 0.935 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 43' ' ' LEU . . . . . 0.899 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 45' ' ' THR . . . . . 0.935 HG23 ' O ' ' 1' ' 41' ' ' ALA . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 46' ' ' ILE . . . . . 0.861 HG13 HG13 ' 1' ' 61' ' ' VAL . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 47' ' ' GLU . . . . . 0.537 ' O ' HG13 ' 1' ' 51' ' ' VAL . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 48' ' ' SER . . . . . 0.77 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 49' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 50' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 51' ' ' VAL . . . . . 0.537 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 53' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 57' ' ' PHE . . . . . 0.589 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 61' ' ' VAL . . . . . 0.861 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 65' ' ' ILE . . . . . 1.003 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 68' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 69' ' ' LEU . . . . . 0.685 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 70' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 72' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 76' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 77' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 79' ' ' ILE . . . . . 1.003 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 81' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 83' ' ' LEU . . . . . 0.722 ' HB2' HD23 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 84' ' ' ARG . . . . . 0.857 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 85' ' ' PRO . . . . . 0.563 ' CD ' ' HD3' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 86' ' ' PRO . . . . . 0.563 ' HD3' ' CD ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 87' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 88' ' ' LYS . . . . . 0.415 ' HD2' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' HD2' ' 1' ' 88' ' ' LYS . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 90' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 93' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 94' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 95' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 96' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 97' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' 1' 1 ' 98' ' ' VAL . . . . . 0.886 HG23 HG13 ' 1' ' 79' ' ' ILE . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 100' ' ' PRO . . . . . 0.653 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 4.9 tp -140.7 144.73 35.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 142.15 51.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.42 153.84 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -66.31 -169.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 151.25 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -102.86 -48.99 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -60.78 164.32 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.771 0.32 . . . . 0.0 110.908 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.463 HG11 ' O ' ' 1' ' 48' ' ' SER . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.642 HD22 HD12 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 1.009 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.579 ' O ' HG12 ' 1' ' 98' ' ' VAL . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.766 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . 0.512 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.998 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.514 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.608 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.879 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 1.009 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.521 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.838 HD13 HG13 ' 1' ' 61' ' ' VAL . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.544 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.463 ' O ' HG11 ' 1' ' 24' ' ' VAL . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' 1' ' 51' ' ' VAL . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.605 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.867 ' O ' HD12 ' 1' ' 65' ' ' ILE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.867 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.702 HD23 HD21 ' 1' ' 72' ' ' LEU . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.998 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.881 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.487 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.572 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.533 HG22 ' CE1' ' 1' ' 81' ' ' PHE . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.729 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.572 HD12 ' O ' ' 1' ' 93' ' ' VAL . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.916 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.593 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' 1' ' 23' ' ' ASN . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.766 HG11 ' CD2' ' 1' ' 31' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.557 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.582 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.9 tp . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.828 0.347 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.745 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.722 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . 0.47 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.853 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.755 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.684 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.755 HG23 ' O ' ' 1' ' 35' ' ' LEU . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.559 ' HA ' HG22 ' 1' ' 45' ' ' THR . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.559 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.851 HG13 HG13 ' 1' ' 61' ' ' VAL . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' N ' HG22 ' 1' ' 46' ' ' ILE . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.485 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.598 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.659 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . 0.456 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.851 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.996 HD13 HG21 ' 1' ' 79' ' ' ILE . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.715 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.755 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.451 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.996 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.536 HD12 ' O ' ' 1' ' 93' ' ' VAL . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.682 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' 1' ' 88' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.418 ' C ' ' HG3' ' 1' ' 87' ' ' PRO . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.745 ' O ' HG12 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.452 ' N ' HD22 ' 1' ' 94' ' ' LEU . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.853 HG11 HD21 ' 1' ' 31' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.644 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 3.5 tp . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.853 0.358 . . . . 0.0 110.881 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.616 HG12 ' H ' ' 1' ' 92' ' ' GLN . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 0.478 HG13 HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.584 ' O ' HG12 ' 1' ' 98' ' ' VAL . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.693 HD13 HG21 ' 1' ' 39' ' ' VAL . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.802 HG23 ' O ' ' 1' ' 35' ' ' LEU . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.445 ' O ' HG13 ' 1' ' 46' ' ' ILE . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.571 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.444 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.4 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.58 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.795 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.795 HG23 ' O ' ' 1' ' 57' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.861 HD13 HG21 ' 1' ' 79' ' ' ILE . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' 1' ' 77' ' ' PRO . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.763 ' HB2' HD22 ' 1' ' 35' ' ' LEU . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.555 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . 0.776 HG22 ' OE2' ' 1' ' 80' ' ' GLU . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.864 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' 1' ' 78' ' ' THR . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.543 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' 1' ' 84' ' ' ARG . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.534 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.996 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.616 ' H ' HG12 ' 1' ' 24' ' ' VAL . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.996 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.401 ' N ' HG22 ' 1' ' 95' ' ' ILE . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.864 HG23 HG13 ' 1' ' 79' ' ' ILE . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.555 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.6 tp . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.807 0.337 . . . . 0.0 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.511 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 1.085 HD11 HD13 ' 1' ' 94' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 1.038 HG13 HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.642 ' O ' HG12 ' 1' ' 98' ' ' VAL . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . 0.484 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 1.038 HD12 HG13 ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.837 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.733 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 1.1 t30 -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.837 HG23 ' O ' ' 1' ' 35' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.614 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.614 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.777 HD12 HD23 ' 1' ' 26' ' ' LEU . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.55 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.568 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.75 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.803 ' O ' HD12 ' 1' ' 65' ' ' ILE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.874 HD13 HG21 ' 1' ' 79' ' ' ILE . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.429 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.877 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.812 HD21 ' NE2' ' 1' ' 92' ' ' GLN . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.602 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' 1' ' 92' ' ' GLN . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.521 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.812 ' NE2' HD21 ' 1' ' 83' ' ' LEU . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.602 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 1.085 HD13 HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.503 HD11 ' NH2' ' 1' ' 84' ' ' ARG . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' 1' ' 26' ' ' LEU . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.877 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 8.6 tp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.547 HG12 ' O ' ' 1' ' 92' ' ' GLN . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 0.759 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.718 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . 0.411 ' O ' HD23 ' 1' ' 31' ' ' LEU . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' 1' ' 39' ' ' VAL . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.722 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . 0.913 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.859 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.913 HG23 ' O ' ' 1' ' 41' ' ' ALA . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 HG13 HG13 ' 1' ' 61' ' ' VAL . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.405 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.456 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.48 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.505 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.942 ' O ' HD12 ' 1' ' 65' ' ' ILE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . 0.859 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.942 HD12 ' O ' ' 1' ' 61' ' ' VAL . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.713 ' CD1' HG21 ' 1' ' 98' ' ' VAL . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.82 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.478 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.591 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.764 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' 1' ' 96' ' ' ALA . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.513 HD12 ' O ' ' 1' ' 93' ' ' VAL . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.849 ' HG2' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.74 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.547 ' O ' HG12 ' 1' ' 24' ' ' VAL . 2.7 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.849 HG23 ' HG2' ' 1' ' 84' ' ' ARG . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.507 HD22 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.553 HD12 ' HE ' ' 1' ' 84' ' ' ARG . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.764 HG23 HG13 ' 1' ' 79' ' ' ILE . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.82 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.707 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 57.3 m-80 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.911 0.386 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.785 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 1.095 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.436 ' O ' HG12 ' 1' ' 98' ' ' VAL . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.717 HD21 HG11 ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 1.048 HD22 HD13 ' 1' ' 72' ' ' LEU . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.484 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.571 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.511 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.0 OUTLIER -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 1.095 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.79 HD12 HD23 ' 1' ' 26' ' ' LEU . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.555 ' N ' HG22 ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.443 ' HB2' HG23 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.564 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.726 ' O ' HG23 ' 1' ' 61' ' ' VAL . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.852 ' O ' HD12 ' 1' ' 65' ' ' ILE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.852 HD12 ' O ' ' 1' ' 61' ' ' VAL . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.803 HD23 HD11 ' 1' ' 72' ' ' LEU . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 1.048 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' 1' ' 35' ' ' LEU . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.727 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.852 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.518 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.566 ' HE ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' 1' ' 91' ' ' ARG . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.785 ' O ' HG12 ' 1' ' 24' ' ' VAL . 1.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.603 ' N ' HD22 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' 1' ' 26' ' ' LEU . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.852 HG23 HG13 ' 1' ' 79' ' ' ILE . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.606 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp . . . . . 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.776 0.322 . . . . 0.0 110.895 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.975 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 1.021 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.961 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.763 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.516 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.4 OUTLIER -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 1.021 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.975 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.567 ' N ' HG22 ' 1' ' 46' ' ' ILE . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.603 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . 0.409 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.62 HG22 HG23 ' 1' ' 46' ' ' ILE . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.853 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.961 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.874 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.504 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.56 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.853 HG21 HD13 ' 1' ' 65' ' ' ILE . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.905 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.82 HD12 HD11 ' 1' ' 26' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.747 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.577 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 4.7 m120 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.797 0.332 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.568 HG12 ' O ' ' 1' ' 92' ' ' GLN . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.782 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.498 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.871 HD21 HG11 ' 1' ' 98' ' ' VAL . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.907 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . 0.417 ' N ' ' HB3' ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.731 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 1.4 t30 -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.907 HG23 ' O ' ' 1' ' 35' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . 0.908 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.437 ' O ' HG12 ' 1' ' 46' ' ' ILE . 0.1 OUTLIER -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.908 HG23 ' O ' ' 1' ' 41' ' ' ALA . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.722 HG13 HG13 ' 1' ' 61' ' ' VAL . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.47 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.486 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.577 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.461 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.722 HG13 HG13 ' 1' ' 46' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.564 HG13 HG13 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.857 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.781 ' CE2' HD12 ' 1' ' 35' ' ' LEU . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.867 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.726 HD11 ' OE1' ' 1' ' 92' ' ' GLN . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' 1' ' 92' ' ' GLN . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.456 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.726 ' OE1' HD11 ' 1' ' 83' ' ' LEU . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.602 ' N ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG11 HD21 ' 1' ' 31' ' ' LEU . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.528 ' HG3' ' CD2' ' 1' ' 74' ' ' TYR . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.647 HD12 ' C ' ' 1' ' 103' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.766 0.317 . . . . 0.0 110.863 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.445 HG12 ' O ' ' 1' ' 92' ' ' GLN . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.769 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 1.031 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.567 ' O ' HG12 ' 1' ' 98' ' ' VAL . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . 0.456 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.706 HD21 HG11 ' 1' ' 98' ' ' VAL . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.7 ' HA ' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.718 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.5 OUTLIER -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 1.031 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.549 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.715 HG23 HG22 ' 1' ' 61' ' ' VAL . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.553 ' N ' HG22 ' 1' ' 46' ' ' ILE . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . 0.569 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.663 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.928 ' O ' HD12 ' 1' ' 65' ' ' ILE . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 0.928 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.718 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . 0.512 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.706 ' HE1' HD22 ' 1' ' 103' ' ' LEU . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.676 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 0.871 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.74 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.458 HD13 HD23 ' 1' ' 94' ' ' LEU . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . 0.445 ' O ' HG12 ' 1' ' 24' ' ' VAL . 7.9 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' 1' ' 82' ' ' ASP . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' 1' ' 26' ' ' LEU . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.589 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.706 HD22 ' HE1' ' 1' ' 74' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.78 0.324 . . . . 0.0 110.904 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 24' ' ' VAL . . . . . 0.77 HG21 ' O ' ' 1' ' 48' ' ' SER . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 26' ' ' LEU . . . . . 0.899 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 27' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 28' ' ' VAL . . . . . 0.892 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 29' ' ' GLU . . . . . 0.856 ' O ' HG12 ' 1' ' 98' ' ' VAL . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 30' ' ' GLY . . . . . 0.466 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 31' ' ' LEU . . . . . 0.804 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 32' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 34' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 35' ' ' LEU . . . . . 0.726 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 37' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 38' ' ' ASN . . . . . 0.685 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 39' ' ' VAL . . . . . 0.726 HG23 ' O ' ' 1' ' 35' ' ' LEU . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 41' ' ' ALA . . . . . 0.935 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 43' ' ' LEU . . . . . 0.899 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 45' ' ' THR . . . . . 0.935 HG23 ' O ' ' 1' ' 41' ' ' ALA . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 46' ' ' ILE . . . . . 0.861 HG13 HG13 ' 1' ' 61' ' ' VAL . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 47' ' ' GLU . . . . . 0.537 ' O ' HG13 ' 1' ' 51' ' ' VAL . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 48' ' ' SER . . . . . 0.77 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 49' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 50' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 51' ' ' VAL . . . . . 0.537 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 53' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 57' ' ' PHE . . . . . 0.589 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 61' ' ' VAL . . . . . 0.861 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 65' ' ' ILE . . . . . 1.003 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 68' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 69' ' ' LEU . . . . . 0.685 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 70' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 72' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 76' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 77' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 79' ' ' ILE . . . . . 1.003 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 81' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 83' ' ' LEU . . . . . 0.722 ' HB2' HD23 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 84' ' ' ARG . . . . . 0.857 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 85' ' ' PRO . . . . . 0.563 ' CD ' ' HD3' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 86' ' ' PRO . . . . . 0.563 ' HD3' ' CD ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 87' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 88' ' ' LYS . . . . . 0.415 ' HD2' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' HD2' ' 1' ' 88' ' ' LYS . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 90' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 93' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 94' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 95' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 96' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 97' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' 1' 1 ' 98' ' ' VAL . . . . . 0.886 HG23 HG13 ' 1' ' 79' ' ' ILE . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 100' ' ' PRO . . . . . 0.653 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 4.9 tp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.81 0.338 . . . . 0.0 111.049 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 0.8 OUTLIER -71.24 97.24 1.52 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.908 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.463 HG11 ' O ' ' 1' ' 48' ' ' SER . 3.3 m -141.82 128.49 19.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.199 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 25.7 mtt85 -149.6 99.72 2.91 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.844 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.642 HD22 HD12 ' 1' ' 46' ' ' ILE . 4.7 mp -68.24 134.53 50.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.926 0.393 . . . . 0.0 110.727 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -86.25 138.74 31.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.515 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 1.009 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -106.41 149.68 9.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.786 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.579 ' O ' HG12 ' 1' ' 98' ' ' VAL . 15.6 mt-10 -151.93 122.95 7.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.942 0.401 . . . . 0.0 111.31 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.3 37.18 4.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.264 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.766 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 5.4 mt -141.53 168.13 20.51 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.069 0.461 . . . . 0.0 111.105 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . 0.512 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.4 m -165.22 161.07 19.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.026 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 52.7 -125.13 28.9 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.219 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . 0.528 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 6.8 tt0 -76.78 -10.24 59.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.66 0.267 . . . . 0.0 111.634 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.998 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -77.19 -56.18 4.79 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.0 110.052 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -60.92 -33.39 73.07 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.648 179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -70.19 -42.48 72.35 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.797 179.832 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.514 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -61.29 -52.96 62.53 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.043 0.449 . . . . 0.0 110.271 179.568 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.608 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 54.7 t -55.81 -36.79 44.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.179 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 21.0 ttt180 -57.64 -45.91 84.86 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.804 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -56.87 -46.64 81.7 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.885 178.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.879 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 21.4 mm-40 -62.5 -46.96 86.07 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 1.009 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.0 OUTLIER -47.99 -33.88 8.5 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.804 179.213 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -78.31 -35.31 47.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.062 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.521 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.7 t -80.7 -10.52 59.72 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.838 HD13 HG13 ' 1' ' 61' ' ' VAL . 41.6 mt -59.59 161.85 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.153 0 CA-C-O 120.894 0.378 . . . . 0.0 111.046 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.544 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -69.0 0.86 4.0 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.463 ' O ' HG11 ' 1' ' 24' ' ' VAL . 0.2 OUTLIER -62.64 9.59 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -179.441 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.47 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 3.6 t0 -77.67 33.83 0.17 Allowed 'General case' 0 CA--C 1.53 0.205 0 O-C-N 122.36 -0.213 . . . . 0.0 111.293 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.0 OUTLIER 87.76 73.34 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.075 0.464 . . . . 0.0 110.652 -179.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.427 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -137.41 -167.02 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.032 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.9 m -99.56 96.0 4.14 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.478 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' 1' ' 51' ' ' VAL . 47.7 Cg_endo -68.95 116.85 4.68 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.322 2.015 . . . . 0.0 112.801 -179.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.28 -177.74 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.177 179.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.95 -29.23 0.79 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.842 0.354 . . . . 0.0 110.957 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.95 -40.38 47.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.853 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.605 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.7 t80 -63.67 -43.54 96.38 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . 0.445 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -53.07 -40.57 64.13 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.843 179.066 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -67.98 -43.2 79.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.914 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.74 -35.34 70.56 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.436 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.867 ' O ' HD12 ' 1' ' 65' ' ' ILE . 22.8 t -71.25 -51.76 31.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.623 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -56.04 -47.01 78.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -58.9 -44.38 91.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.331 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . 0.879 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -56.44 -59.52 4.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.601 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.867 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.8 mp -56.98 -55.98 17.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.632 179.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.465 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 32.0 ttm180 -53.66 -37.61 63.33 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.324 -179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -64.23 -58.39 6.7 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.51 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.2 -35.59 92.28 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.219 -0.991 . . . . 0.0 110.869 178.604 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.702 HD23 HD21 ' 1' ' 72' ' ' LEU . 5.7 mt -69.94 -33.4 72.09 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.275 0.56 . . . . 0.0 109.91 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.639 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 11.7 ttmt -68.17 -20.36 64.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.562 -0.744 . . . . 0.0 111.22 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.65 -3.67 32.6 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 -178.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.998 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.5 pp -117.6 21.17 13.15 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.61 -13.2 7.78 Favored Glycine 0 C--N 1.33 0.196 0 C-N-CA 120.003 -1.094 . . . . 0.0 113.893 179.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.881 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 34.8 m-85 -106.09 171.41 7.36 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.437 0.619 . . . . 0.0 111.355 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -123.68 -47.8 1.94 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.48 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.487 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 79.6 mt-30 -157.55 54.28 0.78 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.299 179.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.572 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 86.9 Cg_exo -49.44 128.48 20.64 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.646 2.231 . . . . 0.0 113.058 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -69.35 103.5 2.01 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.533 HG22 ' CE1' ' 1' ' 81' ' ' PHE . 4.6 mt -111.67 112.57 41.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.09 0.472 . . . . 0.0 111.907 -178.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 3.9 mm-40 -94.88 177.33 5.94 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.965 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.729 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 3.3 m-85 -150.89 157.13 42.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 112.39 -179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.21 94.52 2.76 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.48 179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.572 HD12 ' O ' ' 1' ' 93' ' ' VAL . 55.1 tp -71.19 141.47 50.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.24 0.543 . . . . 0.0 112.21 -178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.916 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -139.06 91.49 11.39 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.54 179.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.536 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 81.8 Cg_exo -47.05 -35.01 18.11 Favored 'Trans proline' 0 CA--C 1.531 0.345 0 C-N-CA 123.094 2.529 . . . . 0.0 114.007 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 65.6 Cg_endo -100.38 75.2 0.05 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 122.916 2.411 . . . . 0.0 113.831 -178.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.593 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 29.5 Cg_endo -61.84 177.3 1.04 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.368 2.046 . . . . 0.0 112.064 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.88 -36.17 11.74 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.081 179.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.58 32.19 4.44 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.234 -0.439 . . . . 0.0 112.113 -179.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.403 ' HA2' ' HB3' ' 1' ' 23' ' ' ASN . . . -156.73 -154.02 6.87 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.689 -1.243 . . . . 0.0 113.423 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.431 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 7.7 mtp180 -106.23 -47.81 3.73 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.0 0.429 . . . . 0.0 110.759 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.48 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.0 OUTLIER -147.23 127.85 14.2 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.337 179.866 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.593 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.4 OUTLIER -117.26 146.65 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-O 121.228 0.537 . . . . 0.0 111.873 -179.534 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.729 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -136.43 116.24 13.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.209 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.916 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 27.3 mt -78.37 150.8 5.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.368 -179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.32 110.75 5.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.583 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.0 OUTLIER -108.43 126.76 53.25 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.258 179.324 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.766 HG11 ' CD2' ' 1' ' 31' ' ' LEU . 7.6 p -102.02 147.9 8.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 121.021 0.439 . . . . 0.0 111.937 -179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 19.3 m -158.6 87.35 2.31 Favored Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.872 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.557 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.8 Cg_endo -89.62 -77.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 123.083 2.522 . . . . 0.0 112.608 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 149.21 -55.52 0.49 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.683 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.5 p -115.49 155.06 16.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.892 0.377 . . . . 0.0 111.543 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.582 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.9 tp -140.95 147.63 39.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.789 179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -102.61 134.89 45.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.909 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 32.0 m170 60.6 79.65 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.846 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -88.11 -42.75 12.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.893 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 67.95 -70.58 0.12 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.5 t-160 -146.72 178.97 7.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.891 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 60.52 91.56 0.05 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.915 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 19.0 p80 . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.206 -0.902 . . . . 0.0 110.913 179.993 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.838 0.351 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -111.1 48.02 0.96 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.848 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.745 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.1 m -144.14 150.43 16.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.251 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -149.05 119.64 7.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.644 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 2.7 mp -70.99 135.78 48.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.047 -179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . 0.444 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -94.86 147.3 23.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.914 -179.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 0.493 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 0.5 OUTLIER -106.91 134.97 47.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.355 -179.904 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.722 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.2 mt-10 -143.78 128.47 18.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.805 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . 0.47 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 83.11 41.89 8.34 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.44 -179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.853 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.4 mt -141.07 157.98 44.56 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.694 0.283 . . . . 0.0 110.636 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.2 m -165.36 158.51 16.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.064 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 57.17 -114.16 5.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.908 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . 0.53 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.1 OUTLIER -87.71 -9.86 52.86 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 -179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.755 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.0 OUTLIER -79.82 -50.02 11.14 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.104 0.478 . . . . 0.0 110.136 179.616 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -64.71 -30.78 71.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.357 179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.53 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -74.4 -42.66 58.86 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.389 179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.684 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -63.29 -47.38 82.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.138 179.335 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.755 HG23 ' O ' ' 1' ' 35' ' ' LEU . 40.6 t -61.41 -40.16 85.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.534 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -55.88 -46.73 78.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.255 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.69 -47.23 86.44 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.202 179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.559 ' HA ' HG22 ' 1' ' 45' ' ' THR . 4.3 mt-30 -64.55 -35.38 80.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.842 179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.5 OUTLIER -60.0 -33.88 72.58 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.127 179.041 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.54 -15.84 34.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.256 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.559 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 0.7 OUTLIER -91.15 -18.4 24.54 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-O 120.702 0.286 . . . . 0.0 110.997 179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.851 HG13 HG13 ' 1' ' 61' ' ' VAL . 2.1 mm -58.37 162.82 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.87 0.367 . . . . 0.0 110.673 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' N ' HG22 ' 1' ' 46' ' ' ILE . 20.5 mt-10 -63.64 0.92 0.67 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.161 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.87 9.63 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.816 0.673 . . . . 0.0 112.816 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.512 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 38.5 t70 -77.84 33.98 0.18 Allowed 'General case' 0 CA--C 1.531 0.227 0 O-C-N 122.377 -0.202 . . . . 0.0 111.018 179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.457 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 4.2 tt0 87.96 73.0 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.209 0 C-N-CA 122.881 0.472 . . . . 0.0 110.741 -179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.485 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.3 m -137.66 -166.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.031 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.598 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.4 t -100.61 94.77 3.78 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.617 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -68.24 117.2 4.78 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.447 2.098 . . . . 0.0 112.707 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -142.19 -177.91 5.47 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.452 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 24.1 mmt180 -44.56 -29.56 0.75 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.325 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.1 -40.45 31.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.916 179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.659 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.1 t80 -61.72 -46.43 89.67 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . 0.456 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 0.9 OUTLIER -56.24 -41.53 75.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.938 179.471 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -64.1 -44.81 91.17 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.13 -47.55 77.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.665 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.851 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.3 t -64.62 -40.39 88.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.205 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.35 -48.18 82.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.201 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -63.8 -46.92 82.98 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.551 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.03 -52.56 41.88 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.021 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.996 HD13 HG21 ' 1' ' 79' ' ' ILE . 5.2 mt -56.81 -57.89 7.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.748 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.444 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.0 -37.11 63.67 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.355 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -62.88 -59.47 4.8 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.445 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.63 -40.41 99.12 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.721 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.3 mt -64.01 -32.92 74.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.112 0.482 . . . . 0.0 109.927 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.715 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.5 ttmt -68.75 -21.81 64.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.71 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -98.31 -4.38 35.15 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 112.739 0.644 . . . . 0.0 112.739 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.721 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -109.63 9.01 25.14 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.01 1.95 7.92 Favored Glycine 0 CA--C 1.516 0.139 0 C-N-CA 120.193 -1.003 . . . . 0.0 114.166 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.755 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 25.5 m-85 -116.5 171.33 7.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.579 0.69 . . . . 0.0 111.301 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -121.13 -49.82 2.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.818 -179.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.451 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 37.1 mt-30 -153.16 54.57 1.21 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.543 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.589 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.4 Cg_exo -48.5 129.79 20.53 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.433 2.088 . . . . 0.0 112.438 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -63.43 103.18 0.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.996 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.8 mt -113.64 112.76 41.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.122 0.486 . . . . 0.0 111.896 -178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -109.32 178.12 4.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.168 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.774 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 75.2 m-85 -144.26 145.38 32.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.017 0.437 . . . . 0.0 111.648 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -121.01 94.62 4.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.034 179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.536 HD12 ' O ' ' 1' ' 93' ' ' VAL . 3.5 tp -80.57 130.13 34.93 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.773 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.682 ' CG ' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.25 90.31 34.81 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.796 178.846 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 88.5 Cg_exo -47.53 -33.9 18.79 Favored 'Trans proline' 0 CA--C 1.532 0.402 0 C-N-CA 123.008 2.472 . . . . 0.0 114.022 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 74.5 Cg_endo -100.74 73.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.947 2.431 . . . . 0.0 113.823 -178.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.736 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 32.6 Cg_endo -63.1 177.48 1.45 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.471 2.114 . . . . 0.0 112.218 179.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.497 ' HD3' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.23 -34.99 11.43 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.412 179.597 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.497 ' HB2' ' HD3' ' 1' ' 88' ' ' LYS . 5.9 tptp -130.62 32.35 4.41 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -158.55 -154.14 7.06 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 119.814 -1.184 . . . . 0.0 113.175 -179.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.418 ' C ' ' HG3' ' 1' ' 87' ' ' PRO . 14.0 mmt85 -105.56 -49.84 3.34 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.872 0.367 . . . . 0.0 110.56 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.745 ' O ' HG12 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -147.48 125.8 12.3 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.507 179.447 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.736 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 m -108.11 141.96 22.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.176 0.512 . . . . 0.0 111.648 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.774 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.9 tm? -136.21 117.12 14.19 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.555 179.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.452 ' N ' HD22 ' 1' ' 94' ' ' LEU . 43.4 mt -92.76 153.01 3.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.337 -179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -135.14 106.28 6.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.157 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 3.7 mtmt -106.65 130.75 54.34 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.783 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.853 HG11 HD21 ' 1' ' 31' ' ' LEU . 9.6 p -118.86 148.93 21.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.466 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.2 m -156.7 90.13 2.61 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.162 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.644 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -88.21 -84.97 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.024 2.482 . . . . 0.0 112.658 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.53 -65.98 0.26 Allowed Glycine 0 C--N 1.335 0.501 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.079 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . 0.433 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.2 p -115.49 149.5 17.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.806 0.336 . . . . 0.0 111.79 -179.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 3.5 tp -140.74 136.8 32.92 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.819 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -99.22 110.1 22.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.87 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 10.6 t60 -96.49 -32.82 12.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -128.32 31.33 5.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.92 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 60.45 158.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.902 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 10.4 p80 -134.7 119.67 18.55 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 24.4 p80 -115.9 -177.59 3.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.914 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 1.7 t60 . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.236 -0.888 . . . . 0.0 110.926 179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.828 0.347 . . . . 0.0 111.031 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.438 ' HB2' ' CG ' ' 1' ' 91' ' ' ARG . 18.3 m120 -102.99 45.65 0.95 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.881 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.616 HG12 ' H ' ' 1' ' 92' ' ' GLN . 33.2 m -142.95 150.14 18.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.345 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 34.8 mtt85 -149.03 124.53 10.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.598 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.825 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.3 OUTLIER -68.21 147.72 51.85 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.883 0.373 . . . . 0.0 111.048 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -98.15 134.39 41.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.762 179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 0.478 HG13 HD12 ' 1' ' 43' ' ' LEU . 0.5 OUTLIER -95.03 127.5 46.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.476 -179.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.584 ' O ' HG12 ' 1' ' 98' ' ' VAL . 19.6 mt-10 -141.42 122.9 15.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.186 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.07 41.14 5.34 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 121.083 -0.579 . . . . 0.0 113.263 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.693 HD13 HG21 ' 1' ' 39' ' ' VAL . 5.0 mt -142.33 158.25 43.92 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.028 0.442 . . . . 0.0 110.961 179.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . 0.445 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 21.8 m -151.52 141.19 21.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.965 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 56.36 -138.87 45.29 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.92 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . 0.407 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 1.6 mp0 -44.33 -35.18 2.23 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.787 0.327 . . . . 0.0 111.516 -179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.89 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 3.5 mt -62.62 -58.3 8.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.488 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -56.77 -32.52 65.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.478 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.8 mttt -74.08 -54.38 7.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.638 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -53.38 -47.1 69.78 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.544 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.802 HG23 ' O ' ' 1' ' 35' ' ' LEU . 29.9 t -59.16 -49.15 84.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.52 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.14 -40.97 25.39 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.994 0.426 . . . . 0.0 110.393 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.52 73.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.336 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.445 ' O ' HG13 ' 1' ' 46' ' ' ILE . 4.8 mt-30 -63.56 -35.16 79.57 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.936 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -62.78 -33.35 75.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.911 179.73 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 36.7 m -80.4 -28.46 37.88 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.122 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.421 ' OG1' ' HA ' ' 1' ' 42' ' ' GLN . 0.2 OUTLIER -82.78 -17.02 45.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.669 -179.705 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 17.0 mt -44.56 161.72 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-O 120.938 0.399 . . . . 0.0 111.613 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.571 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.0 mm-40 -70.11 0.8 5.51 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.771 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.444 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -62.86 9.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -179.619 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.471 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.7 m-20 -73.41 33.93 0.08 Allowed 'General case' 0 CA--C 1.531 0.235 0 O-C-N 122.346 -0.221 . . . . 0.0 111.412 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.3 tt0 87.95 66.33 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.047 0.451 . . . . 0.0 110.839 -179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.4 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.9 m -131.65 -168.08 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.914 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.58 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.6 t -100.56 95.66 4.57 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.836 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.55 117.35 4.66 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 122.344 2.029 . . . . 0.0 112.478 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -146.96 -177.72 5.81 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.599 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.77 -29.75 0.57 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.382 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.92 -39.02 44.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.862 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.795 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.2 t80 -64.87 -43.66 92.23 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -52.47 -62.2 1.8 Allowed 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.254 179.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.34 -41.91 76.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.392 -179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 2.7 mmt85 -54.71 -42.28 71.33 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.66 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.795 HG23 ' O ' ' 1' ' 57' ' ' PHE . 17.3 t -71.2 -49.94 44.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.974 179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -57.46 -36.05 70.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.83 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 15.5 t0 -68.63 -48.57 63.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.621 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.8 -58.54 7.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.664 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.861 HD13 HG21 ' 1' ' 79' ' ' ILE . 6.2 mt -49.49 -56.02 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.258 0 CA-C-O 120.99 0.424 . . . . 0.0 110.142 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.428 ' HG3' ' HD2' ' 1' ' 77' ' ' PRO . 12.2 ttm180 -55.63 -31.72 62.54 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.615 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . 0.509 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.46 -61.14 2.53 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 179.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.509 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -64.78 -44.6 94.53 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.76 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.8 mt -56.4 -36.53 69.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.067 0.461 . . . . 0.0 110.039 178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.6 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 19.9 tttt -67.21 -27.84 67.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.833 179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.22 58.74 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.458 -179.315 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.763 ' HB2' HD22 ' 1' ' 35' ' ' LEU . 0.3 OUTLIER -115.64 19.29 15.4 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 112.309 0.485 . . . . 0.0 112.309 -179.019 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.74 -12.93 7.74 Favored Glycine 0 CA--C 1.516 0.102 0 C-N-CA 120.181 -1.009 . . . . 0.0 114.023 179.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.89 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 39.2 m-85 -101.04 171.62 7.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 117.359 0.58 . . . . 0.0 111.794 -179.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . 0.414 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 16.4 m-85 -125.67 -42.8 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.659 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.515 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 6.4 pt20 -161.54 54.58 0.54 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.618 179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.555 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 51.0 Cg_exo -54.67 132.88 54.11 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.399 2.066 . . . . 0.0 112.904 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . 0.776 HG22 ' OE2' ' 1' ' 80' ' ' GLU . 8.0 m -73.71 103.53 4.32 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.864 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.6 mt -110.61 108.23 24.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.076 0.465 . . . . 0.0 111.854 -178.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . 0.776 ' OE2' HG22 ' 1' ' 78' ' ' THR . 0.4 OUTLIER -101.35 172.77 6.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.113 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.543 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 16.6 m-85 -143.87 146.67 33.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.184 0.516 . . . . 0.0 111.964 -179.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' O ' ' HD2' ' 1' ' 84' ' ' ARG . 50.1 t0 -124.32 99.85 6.41 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.094 179.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.534 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 6.5 tp -72.17 149.31 44.8 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.278 0.561 . . . . 0.0 112.279 -178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.996 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 1.1 mpt_? -141.67 79.4 16.99 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.23 -0.895 . . . . 0.0 109.896 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.518 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 80.5 Cg_exo -44.87 -38.73 13.43 Favored 'Trans proline' 0 CA--C 1.53 0.325 0 C-N-CA 122.72 2.28 . . . . 0.0 113.372 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.518 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 81.4 Cg_endo -102.72 67.05 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 123.355 2.703 . . . . 0.0 113.82 -178.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.51 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 49.8 Cg_endo -69.27 172.78 11.56 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 122.069 1.846 . . . . 0.0 112.102 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.419 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.81 -26.85 14.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.962 -179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 7.7 tptt -129.87 32.16 4.6 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.543 0.571 . . . . 0.0 112.543 -178.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.42 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -170.07 -156.51 11.18 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.693 -1.242 . . . . 0.0 113.246 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' CG ' ' HB2' ' 1' ' 23' ' ' ASN . 6.3 mmm-85 -96.49 -51.21 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.992 0.425 . . . . 0.0 110.292 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.616 ' H ' HG12 ' 1' ' 24' ' ' VAL . 16.7 mt-30 -147.46 116.63 6.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.653 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.996 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 0.9 OUTLIER -85.34 118.52 32.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.648 -179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.745 ' CD1' HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -123.94 110.06 14.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.956 0.408 . . . . 0.0 110.717 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' 1' ' 81' ' ' PHE . 51.0 mt -84.85 153.21 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.306 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.401 ' N ' HG22 ' 1' ' 95' ' ' ILE . . . -136.97 105.6 5.83 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.171 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.68 126.87 52.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.725 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.864 HG23 HG13 ' 1' ' 79' ' ' ILE . 12.7 p -109.95 149.38 12.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.487 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.9 m -157.87 90.54 2.29 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.991 179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.555 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.3 Cg_endo -89.87 -76.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.797 0 C-N-CA 123.064 2.51 . . . . 0.0 112.625 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 152.39 -59.24 0.41 Allowed Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.438 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.4 p -115.55 157.45 16.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.829 0.347 . . . . 0.0 111.423 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' 1' ' 35' ' ' LEU . 6.6 tp -140.94 126.35 18.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.856 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.89 110.14 17.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.855 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -147.59 157.92 43.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.915 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -150.06 166.7 28.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 8.5 m80 60.14 84.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.927 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -71.31 86.44 0.81 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.885 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.6 t60 -92.05 153.55 19.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t-80 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.847 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.331 0 CA-C-O 120.826 0.346 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 1.4 m-80 58.29 79.04 0.22 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.511 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.5 m -147.36 151.74 13.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.268 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 4.9 ptt180 -149.06 127.67 12.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.941 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 1.085 HD11 HD13 ' 1' ' 94' ' ' LEU . 0.4 OUTLIER -80.13 120.68 24.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.898 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 2.2 mm100 -74.71 128.49 35.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.748 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 1.038 HG13 HD12 ' 1' ' 31' ' ' LEU . 38.9 t -83.96 113.25 22.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.348 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.642 ' O ' HG12 ' 1' ' 98' ' ' VAL . 8.5 mt-10 -133.2 123.0 24.81 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.931 0.396 . . . . 0.0 111.211 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . 0.484 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 85.83 37.5 9.34 Favored Glycine 0 N--CA 1.453 -0.21 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.954 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 1.038 HD12 HG13 ' 1' ' 28' ' ' VAL . 16.3 mt -139.56 156.38 46.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.75 0.31 . . . . 0.0 110.484 179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 2.9 m -165.27 -179.7 5.75 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.985 -179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . 0.442 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 46.42 -110.16 0.47 Allowed Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.555 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -95.35 -22.53 17.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.801 0.334 . . . . 0.0 110.892 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.837 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.7 OUTLIER -58.36 -57.78 11.42 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.115 -179.826 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -55.3 -33.02 62.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.949 -0.568 . . . . 0.0 110.899 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 16.8 mtpt -72.08 -49.3 37.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.42 179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.733 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 1.1 t30 -58.7 -47.01 86.03 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.111 -0.495 . . . . 0.0 109.987 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.837 HG23 ' O ' ' 1' ' 35' ' ' LEU . 20.8 t -59.34 -37.16 67.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.286 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 24.0 ttt-85 -57.74 -46.21 84.79 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.893 179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.86 -42.25 84.11 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 178.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.614 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.8 OUTLIER -68.18 -34.23 75.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.886 178.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.654 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 3.0 mt -60.27 -32.57 71.3 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.558 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 7.1 t -82.2 -33.16 29.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.186 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.614 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.8 t -80.61 -11.47 59.64 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.777 HD12 HD23 ' 1' ' 26' ' ' LEU . 10.2 mt -49.79 161.33 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-O 120.823 0.344 . . . . 0.0 111.247 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.55 ' N ' HG22 ' 1' ' 46' ' ' ILE . 2.3 mm-40 -71.92 0.68 8.62 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.77 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.424 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.1 OUTLIER -65.04 9.87 0.09 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.489 0.552 . . . . 0.0 112.489 -179.677 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.46 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 24.0 t70 -74.68 34.1 0.1 Allowed 'General case' 0 CA--C 1.531 0.228 0 O-C-N 122.418 -0.177 . . . . 0.0 111.352 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.46 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 5.4 tt0 87.94 70.49 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 121.153 0.501 . . . . 0.0 110.648 -179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.8 m -136.03 -167.0 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.909 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.568 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.5 t -109.08 97.25 24.19 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.677 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -54.08 116.98 3.41 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.44 2.093 . . . . 0.0 112.655 -179.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.23 -177.95 5.96 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.734 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.97 -28.44 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.118 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.87 -39.4 35.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.837 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.75 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.5 t80 -63.58 -46.1 87.41 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -52.36 -59.84 3.93 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.08 -0.964 . . . . 0.0 111.091 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.46 -43.17 75.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.281 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -46.33 75.46 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.754 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.803 ' O ' HD12 ' 1' ' 65' ' ' ILE . 6.8 t -69.5 -43.96 80.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.664 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -61.87 -41.26 97.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.613 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -70.25 -40.71 74.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.578 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.11 -56.23 22.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.827 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.874 HD13 HG21 ' 1' ' 79' ' ' ILE . 3.7 mt -55.96 -57.16 9.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.776 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 30.6 ttm180 -53.95 -35.57 61.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.178 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -62.75 -59.72 4.49 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.79 -41.29 99.88 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.529 -1.028 . . . . 0.0 110.529 178.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 5.6 mt -62.74 -32.19 73.26 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.126 0.489 . . . . 0.0 109.905 178.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.721 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 14.7 ttmt -69.2 -23.14 63.86 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.736 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -97.62 -4.43 37.55 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.7 OUTLIER -108.91 9.12 26.68 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.312 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.99 1.49 8.05 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.184 -1.008 . . . . 0.0 114.161 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.2 m-85 -116.82 171.54 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 117.535 0.667 . . . . 0.0 111.515 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -120.92 -54.71 2.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.664 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.429 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 21.1 mt-30 -147.49 54.57 1.97 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.555 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.562 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 80.3 Cg_exo -48.42 129.14 19.03 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.302 2.001 . . . . 0.0 112.441 179.485 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.1 m -64.67 103.07 0.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.877 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.8 mt -112.2 107.63 23.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.454 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . 0.421 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 0.1 OUTLIER -97.21 165.38 12.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.623 179.818 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.577 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 23.1 m-85 -136.15 132.53 36.13 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.844 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . 0.415 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 37.4 t70 -124.1 94.62 4.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.748 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.812 HD21 ' NE2' ' 1' ' 92' ' ' GLN . 5.0 tp -97.66 146.36 25.4 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.685 -178.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.602 ' HD3' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -139.13 102.89 7.39 Favored Pre-proline 0 C--O 1.238 0.449 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.101 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' 1' ' 92' ' ' GLN . 80.8 Cg_exo -48.36 -36.47 30.34 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.853 2.369 . . . . 0.0 113.215 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 64.9 Cg_endo -103.36 69.31 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.47 2.78 . . . . 0.0 113.469 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.521 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 31.7 Cg_endo -63.7 175.94 2.61 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.196 1.931 . . . . 0.0 111.993 179.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.421 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.76 -28.33 14.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.287 -0.415 . . . . 0.0 112.051 -179.398 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.421 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 2.1 tptt -129.95 32.24 4.57 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -178.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -170.01 -155.9 10.58 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 119.665 -1.255 . . . . 0.0 113.278 179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.435 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -98.14 -49.97 4.54 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.048 0.451 . . . . 0.0 110.36 179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.812 ' NE2' HD21 ' 1' ' 83' ' ' LEU . 0.8 OUTLIER -147.54 132.78 18.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.351 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.602 HG12 ' HD3' ' 1' ' 84' ' ' ARG . 2.8 t -114.53 137.95 46.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.132 -179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 1.085 HD13 HD11 ' 1' ' 26' ' ' LEU . 0.1 OUTLIER -136.16 119.83 17.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.4 179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.503 HD11 ' NH2' ' 1' ' 84' ' ' ARG . 3.9 mt -94.28 148.28 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.781 0.324 . . . . 0.0 111.318 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.645 ' HB2' HD12 ' 1' ' 26' ' ' LEU . . . -130.6 101.65 5.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.986 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' 1' ' 95' ' ' ILE . 0.1 OUTLIER -106.16 115.42 30.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 -179.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.877 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.0 p -107.16 145.73 14.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.306 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 63.2 m -155.54 90.1 2.9 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.109 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.643 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.7 Cg_endo -87.28 -84.32 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 162.43 -67.62 0.24 Allowed Glycine 0 C--N 1.334 0.467 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.92 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . 0.423 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.4 p -115.56 152.61 17.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.807 0.337 . . . . 0.0 111.669 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 8.6 tp -132.26 129.62 39.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.886 179.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -75.62 142.32 42.66 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.929 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -164.96 99.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.905 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -148.6 -47.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 19.6 p-80 -138.65 124.49 19.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.862 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -128.88 -179.38 5.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.894 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 15.0 m170 -80.26 84.47 5.92 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 4.9 m170 . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.904 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . 0.543 ' HB2' ' HB2' ' 1' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.875 0.369 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -79.01 75.86 5.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.983 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.547 HG12 ' O ' ' 1' ' 92' ' ' GLN . 33.2 m -148.42 150.93 13.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.209 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 5.1 mpt_? -149.17 121.57 8.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.701 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.33 132.69 47.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.938 0.399 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 5.7 tt0 -91.83 136.62 33.01 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.878 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 0.759 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.2 OUTLIER -101.06 133.19 45.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.494 -179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.718 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.7 mt-10 -142.77 123.37 14.09 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.629 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . 0.411 ' O ' HD23 ' 1' ' 31' ' ' LEU . . . 91.42 42.12 4.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.503 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.683 ' CD1' HG21 ' 1' ' 39' ' ' VAL . 14.4 mt -142.45 160.22 40.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.734 0.302 . . . . 0.0 110.743 -179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.0 m -165.37 177.7 7.35 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.188 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 46.89 -111.89 0.81 Allowed Glycine 0 C--N 1.331 0.287 0 C-N-CA 121.067 -0.587 . . . . 0.0 112.752 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.95 -22.82 18.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.834 0.349 . . . . 0.0 110.853 179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.649 HD12 HD22 ' 1' ' 69' ' ' LEU . 0.4 OUTLIER -58.87 -56.92 15.98 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -53.61 -30.56 43.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.811 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 10.1 mtpt -73.36 -53.15 11.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.477 179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.722 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.5 OUTLIER -54.85 -49.02 72.13 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.537 179.652 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.683 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 32.4 t -58.4 -43.37 86.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.327 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.8 -38.34 64.43 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.091 179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . 0.913 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -63.95 -50.74 67.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.966 179.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.859 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 30.3 mm-40 -60.7 -32.77 71.99 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.094 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.2 mt -60.67 -44.36 96.56 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.547 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.2 m -77.97 -17.55 57.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.32 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.913 HG23 ' O ' ' 1' ' 41' ' ' ALA . 41.9 p -81.72 -26.48 34.54 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.76 0.314 . . . . 0.0 110.987 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.825 HG13 HG13 ' 1' ' 61' ' ' VAL . 5.4 mm -52.28 160.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 111.522 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.586 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -69.01 1.76 3.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.253 179.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.405 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -55.13 9.6 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.586 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 11.5 t70 -77.84 34.04 0.18 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.473 0.178 . . . . 0.0 110.952 179.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.543 ' HB2' ' HB2' ' 1' ' 22' ' ' ALA . 0.9 OUTLIER 88.07 74.99 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 122.963 0.505 . . . . 0.0 110.661 -179.256 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.48 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.5 m -139.75 -166.94 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.991 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.4 m -98.2 100.92 9.84 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.632 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.02 117.13 4.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.365 2.043 . . . . 0.0 112.741 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -147.14 -177.74 5.84 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.482 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 6.5 ttt-85 -44.59 -29.08 0.67 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.204 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.37 -39.44 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.76 179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.505 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.4 t80 -62.44 -46.83 86.76 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -51.98 -48.16 64.51 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.018 -0.992 . . . . 0.0 111.065 179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.13 -45.16 91.66 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.038 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 23.8 mmt180 -53.71 -46.97 70.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.567 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.942 ' O ' HD12 ' 1' ' 65' ' ' ILE . 2.8 t -68.23 -46.54 80.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.152 179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -53.89 -46.46 71.38 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.227 179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -65.32 -40.39 93.67 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.255 179.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . 0.859 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.58 -61.14 2.55 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.014 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.942 HD12 ' O ' ' 1' ' 61' ' ' VAL . 3.0 mp -54.01 -56.0 11.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 120.86 0.362 . . . . 0.0 110.806 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.456 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 19.9 ttt-85 -49.9 -37.61 32.24 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.161 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -62.1 -59.04 5.65 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -62.03 -43.42 99.19 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.654 178.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.713 ' CD1' HG21 ' 1' ' 98' ' ' VAL . 7.0 mt -61.46 -32.18 72.16 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.108 0.48 . . . . 0.0 110.092 178.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 17.3 ttmt -68.75 -23.22 64.3 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.823 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.53 -4.4 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.036 0.754 . . . . 0.0 113.036 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.722 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.5 OUTLIER -110.11 12.46 23.49 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.447 0.536 . . . . 0.0 112.447 -178.888 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 124.57 -12.55 7.86 Favored Glycine 0 N--CA 1.455 -0.047 0 C-N-CA 120.075 -1.06 . . . . 0.0 113.809 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.82 ' CE1' ' HG2' ' 1' ' 100' ' ' PRO . 61.5 m-85 -104.56 171.27 7.42 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 117.21 0.505 . . . . 0.0 111.312 -179.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -119.34 -59.18 1.86 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.805 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.478 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 26.1 mt-30 -145.47 54.43 2.37 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.403 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.591 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 84.9 Cg_exo -49.63 131.69 29.04 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.432 2.088 . . . . 0.0 112.648 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 1.5 m -66.54 103.34 1.04 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.764 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -112.54 102.93 14.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.151 0.5 . . . . 0.0 111.62 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -94.95 170.93 9.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.245 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.417 ' CD1' ' HB2' ' 1' ' 96' ' ' ALA . 67.6 m-85 -141.95 140.43 32.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.187 0.518 . . . . 0.0 111.938 -179.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 28.7 t0 -126.96 94.58 4.07 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.764 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.513 HD12 ' O ' ' 1' ' 93' ' ' VAL . 5.4 tp -90.58 142.54 27.65 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.518 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.849 ' HG2' HG23 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -132.51 93.31 25.26 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.053 179.533 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.537 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 87.7 Cg_exo -46.83 -34.24 15.62 Favored 'Trans proline' 0 CA--C 1.532 0.388 0 C-N-CA 122.855 2.37 . . . . 0.0 113.777 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.537 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.0 Cg_endo -101.33 71.54 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 123.079 2.519 . . . . 0.0 113.682 -178.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.74 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 34.2 Cg_endo -64.22 177.32 2.08 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.438 2.092 . . . . 0.0 112.17 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.51 -34.75 11.93 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.49 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -130.44 32.17 4.48 Favored 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 112.358 0.503 . . . . 0.0 112.358 -178.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.437 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -160.54 -156.47 8.22 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 119.638 -1.268 . . . . 0.0 113.297 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -99.46 -54.67 2.88 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.823 0.344 . . . . 0.0 110.63 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.547 ' O ' HG12 ' 1' ' 24' ' ' VAL . 2.7 mt-30 -147.5 124.8 11.55 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.625 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.849 HG23 ' HG2' ' 1' ' 84' ' ' ARG . 2.5 m -102.23 143.14 15.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.011 0.434 . . . . 0.0 111.61 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.507 HD22 ' N ' ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -136.39 131.12 33.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.709 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.553 HD12 ' HE ' ' 1' ' 84' ' ' ARG . 23.4 mt -112.6 152.94 14.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.14 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.461 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -143.15 112.75 6.9 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.402 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.79 126.78 54.97 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.654 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.764 HG23 HG13 ' 1' ' 79' ' ' ILE . 7.9 p -108.44 144.93 16.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.878 0.37 . . . . 0.0 111.533 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 31.1 m -154.19 89.58 3.32 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.084 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.82 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 25.2 Cg_endo -88.89 -82.96 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.677 0 C-N-CA 123.172 2.581 . . . . 0.0 112.86 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 154.91 -58.17 0.4 Allowed Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.729 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . 0.421 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 2.3 p -115.53 156.41 16.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.86 0.362 . . . . 0.0 111.738 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.707 HD13 ' CE2' ' 1' ' 74' ' ' TYR . 5.2 tp -140.95 132.13 26.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.726 179.063 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.41 153.53 22.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.91 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -112.11 -177.89 3.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.909 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 60.75 93.89 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.909 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 m-70 -132.95 115.71 15.54 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.887 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 13.3 m80 -97.94 160.9 14.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.878 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -136.57 94.29 2.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.201 -0.904 . . . . 0.0 110.869 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . 0.683 ' HB2' ' HG3' ' 1' ' 50' ' ' GLU . . . . . . . . 0 N--CA 1.487 1.401 0 CA-C-O 120.741 0.305 . . . . 0.0 110.975 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.431 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 57.3 m-80 -105.13 47.07 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.831 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.785 HG12 ' O ' ' 1' ' 92' ' ' GLN . 34.8 m -126.91 151.71 34.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.145 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.3 ptm180 -149.0 126.1 11.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.823 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -72.09 137.04 46.8 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.681 179.838 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . 0.401 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 2.1 tm0? -100.24 115.23 29.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.946 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 1.095 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -85.18 128.46 39.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.211 179.901 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.436 ' O ' HG12 ' 1' ' 98' ' ' VAL . 13.4 mt-10 -143.11 122.9 13.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.29 37.9 2.76 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.931 -0.652 . . . . 0.0 113.235 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.717 HD21 HG11 ' 1' ' 98' ' ' VAL . 4.6 mt -144.22 156.05 44.14 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.973 0.416 . . . . 0.0 110.873 179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 24.2 m -144.21 140.97 29.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.992 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . 0.431 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 57.63 -140.63 45.49 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.724 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . 0.408 ' HA ' ' HG3' ' 1' ' 37' ' ' LYS . 0.7 OUTLIER -45.01 -32.93 1.84 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.866 0.365 . . . . 0.0 111.491 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 1.048 HD22 HD13 ' 1' ' 72' ' ' LEU . 5.7 mt -62.52 -58.18 8.52 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.471 179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.7 -34.27 72.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.895 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 2.7 mtmt -68.91 -47.75 65.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.88 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.484 ' CB ' HD23 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -57.93 -56.16 25.62 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 120.885 0.374 . . . . 0.0 110.787 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.571 ' CG2' HD13 ' 1' ' 31' ' ' LEU . 40.4 t -55.8 -35.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.664 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . 0.466 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 2.4 mtm180 -58.76 -44.61 90.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.001 0.429 . . . . 0.0 109.895 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -59.79 -42.9 94.42 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.511 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.0 OUTLIER -64.87 -36.88 85.77 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.714 178.73 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 1.095 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -56.49 -39.1 72.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.583 179.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 3.5 m -75.12 -32.62 61.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.12 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.2 t -81.25 -10.97 59.5 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.79 HD12 HD23 ' 1' ' 26' ' ' LEU . 14.6 mt -52.97 161.31 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-O 120.863 0.363 . . . . 0.0 111.222 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.555 ' N ' HG22 ' 1' ' 46' ' ' ILE . 0.9 OUTLIER -70.6 0.75 6.25 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.901 179.958 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.443 ' HB2' HG23 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -64.15 9.78 0.07 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.462 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 2.4 t70 -74.17 34.18 0.09 Allowed 'General case' 0 CA--C 1.532 0.264 0 O-C-N 122.437 -0.164 . . . . 0.0 111.356 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.683 ' HG3' ' HB2' ' 1' ' 22' ' ' ALA . 0.0 OUTLIER 88.07 70.28 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.084 0.469 . . . . 0.0 110.64 -179.416 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 m -137.37 -170.98 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.021 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.564 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.8 t -101.55 99.28 11.09 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.674 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -64.38 117.1 4.17 Favored 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.251 1.967 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -147.13 -177.92 5.93 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.409 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.36 -29.74 0.72 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.888 0.375 . . . . 0.0 111.21 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 2.8 ptp180 -76.44 -42.34 44.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.806 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.726 ' O ' HG23 ' 1' ' 61' ' ' VAL . 3.8 t80 -63.96 -40.74 97.11 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.5 -63.29 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.68 178.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -54.67 -42.55 71.5 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.933 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 30.4 mtt85 -52.01 -45.13 64.46 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.445 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.852 ' O ' HD12 ' 1' ' 65' ' ' ILE . 14.3 t -73.34 -51.12 26.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.656 179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 7.9 t0 -54.4 -37.76 65.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.583 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -72.91 -35.78 67.15 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.201 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.68 -60.61 3.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.93 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.852 HD12 ' O ' ' 1' ' 61' ' ' VAL . 4.1 mp -54.48 -56.75 8.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.027 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.403 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 10.3 ttt-85 -46.47 -47.98 19.11 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.486 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -59.99 -55.98 27.34 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.53 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -63.0 -28.05 71.42 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.338 -0.934 . . . . 0.0 111.284 178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.803 HD23 HD11 ' 1' ' 72' ' ' LEU . 7.7 mt -78.49 -27.42 46.19 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-O 121.241 0.543 . . . . 0.0 110.16 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.711 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.5 ttmt -75.36 -16.35 60.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.107 178.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.67 -3.77 32.33 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -178.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 1.048 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.3 pp -122.01 15.4 10.77 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -178.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . 0.63 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 115.57 -13.31 18.15 Favored Glycine 0 C--O 1.228 -0.246 0 C-N-CA 120.094 -1.05 . . . . 0.0 113.404 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.787 ' CE1' HD13 ' 1' ' 35' ' ' LEU . 3.2 m-85 -100.42 100.01 10.72 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 117.017 0.408 . . . . 0.0 111.675 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -51.03 -84.38 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -179.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.406 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 88.1 mt-30 -132.17 60.19 49.37 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-O 120.809 0.338 . . . . 0.0 111.903 -178.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.727 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 77.6 Cg_exo -51.35 153.65 9.63 Favored 'Trans proline' 0 CA--C 1.519 -0.235 0 C-N-CA 122.794 2.329 . . . . 0.0 113.249 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -91.08 103.33 16.05 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 177.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.852 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.0 mt -110.09 110.71 33.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.859 -178.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . 0.419 ' O ' ' CD1' ' 1' ' 81' ' ' PHE . 38.8 mt-10 -105.99 174.4 5.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.317 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.605 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 24.9 m-85 -141.06 145.7 36.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.051 0.453 . . . . 0.0 111.804 -179.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -129.05 94.83 3.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.375 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.518 HD13 ' HG ' ' 1' ' 94' ' ' LEU . 5.0 tp -69.8 133.28 47.25 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.566 ' HE ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -131.34 88.52 43.86 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.594 179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.54 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 6.3 Cg_endo -50.47 -30.33 27.14 Favored 'Trans proline' 0 CA--C 1.534 0.475 0 C-N-CA 123.003 2.469 . . . . 0.0 114.6 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 90.3 Cg_endo -100.44 71.95 0.05 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 122.682 2.255 . . . . 0.0 113.854 -178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.547 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 36.3 Cg_endo -64.94 176.13 3.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.238 1.959 . . . . 0.0 112.005 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.416 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.89 -31.29 12.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.408 179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.416 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 18.7 ttpp -130.21 32.35 4.5 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.421 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.05 -156.05 8.62 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.696 -1.24 . . . . 0.0 113.43 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.438 ' N ' ' HD3' ' 1' ' 91' ' ' ARG . 7.9 mpt_? -100.46 -50.34 3.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.82 0.343 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.785 ' O ' HG12 ' 1' ' 24' ' ' VAL . 1.6 mt-30 -147.17 131.13 17.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.81 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.547 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.8 OUTLIER -117.72 149.35 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 CA-C-O 120.934 0.397 . . . . 0.0 111.401 -179.772 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.605 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -136.01 122.07 20.17 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.378 179.464 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.603 ' N ' HD22 ' 1' ' 94' ' ' LEU . 36.5 mt -91.06 147.8 5.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.901 0.382 . . . . 0.0 111.445 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.547 ' HB2' ' CD1' ' 1' ' 26' ' ' LEU . . . -133.37 117.08 16.85 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.999 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -119.5 126.13 50.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.143 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.852 HG23 HG13 ' 1' ' 79' ' ' ILE . 8.5 p -107.24 144.3 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.928 179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.6 m -145.7 86.34 7.35 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.517 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.606 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 19.5 Cg_endo -93.55 -76.38 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 123.478 2.785 . . . . 0.0 112.127 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 117.56 -24.28 9.17 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 120.843 -0.694 . . . . 0.0 113.314 179.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 8.9 p -116.12 146.54 20.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 N-CA-C 112.26 0.467 . . . . 0.0 112.26 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.63 ' HA ' ' O ' ' 1' ' 73' ' ' GLY . 2.4 tp -140.96 140.08 34.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.585 178.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -61.13 170.07 1.8 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.854 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -166.68 145.8 5.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.946 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 -100.26 -37.64 8.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.864 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 68.9 m-70 -136.21 159.82 40.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.853 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -150.35 106.7 3.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.855 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 t60 60.18 173.88 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.924 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 29.8 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.903 179.975 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.428 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 3.4 m120 60.71 85.08 0.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . . . . . . . . . 25.3 m -150.87 146.77 16.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.971 0.415 . . . . 0.0 111.398 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.1 118.92 7.06 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.294 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.975 HD22 ' CD1' ' 1' ' 46' ' ' ILE . 0.6 OUTLIER -68.25 152.6 45.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.073 0.464 . . . . 0.0 111.491 -179.486 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -107.0 124.06 49.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.68 179.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 1.021 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -93.59 129.81 43.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.154 -179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -142.09 122.89 14.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.007 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 100.23 38.85 3.43 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.939 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.728 ' CD2' HG11 ' 1' ' 98' ' ' VAL . 8.4 mt -141.28 153.26 45.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.932 0.396 . . . . 0.0 111.019 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . 0.425 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 4.5 m -145.55 -178.77 6.26 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.381 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 43.54 -114.33 0.88 Allowed Glycine 0 C--N 1.334 0.422 0 CA-C-N 115.956 -0.566 . . . . 0.0 112.89 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -91.34 -17.16 26.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.849 0.357 . . . . 0.0 110.744 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.961 HD22 HD13 ' 1' ' 72' ' ' LEU . 3.1 mt -56.88 -62.23 1.89 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.125 0.488 . . . . 0.0 110.849 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -52.02 -35.54 47.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.472 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.41 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 7.5 mtpt -71.73 -48.44 47.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.66 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -56.65 -51.78 67.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.018 0.437 . . . . 0.0 110.577 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.763 ' CG2' HD21 ' 1' ' 69' ' ' LEU . 45.3 t -58.52 -38.34 69.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.654 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -48.26 73.47 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 121.042 0.449 . . . . 0.0 109.965 179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -57.83 -42.14 83.73 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.746 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.516 ' O ' HG13 ' 1' ' 46' ' ' ILE . 0.4 OUTLIER -66.29 -39.86 89.66 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.775 178.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 1.021 HD11 HG13 ' 1' ' 28' ' ' VAL . 1.3 mt -54.15 -36.09 62.94 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.687 179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 49.6 p -79.13 -34.93 42.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.366 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.479 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.3 t -76.8 -11.92 59.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 111.933 0.346 . . . . 0.0 111.933 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.975 ' CD1' HD22 ' 1' ' 26' ' ' LEU . 13.3 mt -53.41 161.98 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.267 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.567 ' N ' HG22 ' 1' ' 46' ' ' ILE . 4.2 mm-40 -70.82 0.78 6.46 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.777 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.432 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -62.55 9.72 0.04 OUTLIER 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 -179.593 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 4.9 m-20 -74.16 34.09 0.09 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 111.411 0.152 . . . . 0.0 111.411 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.462 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.3 OUTLIER 87.94 68.44 0.01 OUTLIER 'General case' 0 C--O 1.231 0.096 0 C-N-CA 123.011 0.524 . . . . 0.0 110.758 -179.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 4.9 m -133.62 -167.42 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.901 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 95.0 m -100.94 96.15 5.35 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.629 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.85 117.01 4.83 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.314 2.009 . . . . 0.0 112.7 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -147.13 -177.8 5.87 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.344 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.85 -29.37 0.54 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.276 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 5.0 ptp180 -78.25 -40.62 36.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.019 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.603 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.0 t80 -62.84 -43.79 97.86 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . 0.409 ' HG3' ' CD2' ' 1' ' 81' ' ' PHE . 0.0 OUTLIER -55.06 -51.68 65.6 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.918 -1.037 . . . . 0.0 111.159 179.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.36 -45.01 84.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.32 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 9.4 mmt180 -55.02 -45.0 75.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 110.601 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.62 HG22 HG23 ' 1' ' 46' ' ' ILE . 14.0 t -69.57 -46.8 74.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.466 179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -55.57 -38.46 69.38 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.392 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -73.66 -43.66 58.83 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.393 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -55.65 -54.1 48.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.845 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.853 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.0 mt -57.26 -57.22 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.752 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 17.6 ttm180 -53.52 -37.53 62.88 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.423 -179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -65.29 -57.87 7.36 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.456 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.98 -30.67 78.63 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.079 178.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.763 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 5.2 mt -74.01 -37.0 64.52 Favored 'General case' 0 CA--C 1.519 -0.214 0 CA-C-O 121.331 0.586 . . . . 0.0 109.904 179.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 30.0 tttt -67.02 -16.31 64.28 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.375 -0.829 . . . . 0.0 111.093 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -99.39 -3.85 32.89 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.961 HD13 HD22 ' 1' ' 35' ' ' LEU . 1.1 pp -118.44 22.48 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.059 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' 1' ' 103' ' ' LEU . . . 124.64 -12.97 7.79 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.953 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.874 ' CE2' HD13 ' 1' ' 35' ' ' LEU . 31.6 m-85 -104.44 171.66 7.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 117.467 0.634 . . . . 0.0 111.879 -179.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' 1' ' 70' ' ' LYS . 11.3 m-85 -124.51 -43.11 2.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.58 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.504 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.0 OUTLIER -162.55 54.88 0.49 Allowed Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.406 179.612 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.56 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 60.7 Cg_exo -53.41 132.54 49.05 Favored 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.492 2.128 . . . . 0.0 112.907 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.85 103.38 5.06 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 178.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.853 HG21 HD13 ' 1' ' 65' ' ' ILE . 3.3 mt -109.72 111.82 37.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.012 0.434 . . . . 0.0 111.779 -178.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -99.83 168.08 10.12 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.355 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.727 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 54.1 m-85 -136.75 153.44 50.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.65 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -138.13 94.67 2.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.409 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.47 ' HA ' HD23 ' 1' ' 94' ' ' LEU . 6.6 tp -68.64 135.78 51.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.978 -0.556 . . . . 0.0 111.901 -179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.905 ' CZ ' HD11 ' 1' ' 95' ' ' ILE . 0.0 OUTLIER -137.93 90.83 13.78 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.509 -0.769 . . . . 0.0 109.557 179.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.538 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 5.2 Cg_endo -50.19 -31.85 30.33 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 122.821 2.347 . . . . 0.0 114.318 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.538 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 97.3 Cg_endo -101.21 73.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.748 2.299 . . . . 0.0 113.816 -178.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.536 ' HB3' HG13 ' 1' ' 93' ' ' VAL . 27.9 Cg_endo -60.99 177.33 0.71 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.37 2.047 . . . . 0.0 112.115 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.39 -36.11 12.06 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.176 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 32.22 4.46 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.297 -0.411 . . . . 0.0 112.065 -179.053 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -157.52 -154.15 6.98 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 119.74 -1.219 . . . . 0.0 113.235 -179.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.428 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -107.7 -45.02 4.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.884 0.373 . . . . 0.0 110.952 -179.893 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.467 ' HG2' ' HA ' ' 1' ' 85' ' ' PRO . 0.9 OUTLIER -147.28 130.57 16.56 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.631 179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.536 HG13 ' HB3' ' 1' ' 87' ' ' PRO . 0.5 OUTLIER -123.55 147.35 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.125 0.488 . . . . 0.0 112.012 -179.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.82 HD12 HD11 ' 1' ' 26' ' ' LEU . 0.4 OUTLIER -136.36 115.84 12.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.265 179.157 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.905 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 51.2 mt -76.63 151.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.845 0.355 . . . . 0.0 111.447 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -144.31 105.29 4.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.131 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 38.6 mtmt -109.77 129.59 55.61 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.646 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.747 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.1 p -109.38 144.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.812 0.339 . . . . 0.0 111.512 -179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 62.8 m -154.51 90.75 3.12 Favored Pre-proline 0 C--N 1.331 -0.226 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.085 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.577 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.6 Cg_endo -89.76 -76.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 123.051 2.501 . . . . 0.0 112.574 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 151.95 -56.19 0.45 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.659 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 5.9 p -115.52 155.14 16.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.876 0.37 . . . . 0.0 111.548 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.583 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 6.9 tp -140.98 148.73 40.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.818 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 22.7 mm-40 -63.75 122.1 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.844 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 12.6 p80 -87.24 152.73 22.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -100.05 28.14 5.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.031 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 64.48 -78.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.004 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER 65.55 -77.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.896 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 27.8 m-70 -92.95 179.61 5.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.891 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 15.0 m-70 . . . . . 0 C--O 1.25 1.079 0 CA-C-O 118.241 -0.885 . . . . 0.0 110.901 -179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.332 0 CA-C-O 120.842 0.353 . . . . 0.0 111.074 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 91' ' ' ARG . 4.7 m120 -140.03 80.23 1.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.568 HG12 ' O ' ' 1' ' 92' ' ' GLN . 22.4 m -145.88 149.52 16.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.269 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.15 122.34 8.93 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.812 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.782 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 3.1 mp -75.43 128.95 36.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.89 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . . . . . . . . . 5.6 mt-30 -85.71 151.41 23.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 0.505 ' HB ' HD12 ' 1' ' 31' ' ' LEU . 2.1 m -104.98 137.58 33.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.336 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.498 ' O ' HG12 ' 1' ' 98' ' ' VAL . 1.6 mt-10 -145.21 127.39 15.7 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 46.31 9.2 Favored Glycine 0 N--CA 1.452 -0.238 0 C-N-CA 120.913 -0.66 . . . . 0.0 112.725 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.871 HD21 HG11 ' 1' ' 98' ' ' VAL . 14.1 mt -141.07 148.32 40.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.734 0.302 . . . . 0.0 110.715 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 3.2 m -151.56 174.86 12.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.882 0.372 . . . . 0.0 111.256 -179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 50.11 -113.24 1.83 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.637 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.03 -14.84 23.95 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.716 0.293 . . . . 0.0 111.06 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.907 ' O ' HG23 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -63.71 -54.65 32.1 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.929 0.395 . . . . 0.0 110.832 179.965 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . 0.417 ' N ' ' HB3' ' 1' ' 31' ' ' LEU . 0.0 OUTLIER -56.41 -35.25 67.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.585 179.771 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . . . . . . . . . 2.6 mtpp -69.46 -53.82 17.32 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.486 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.731 ' CG ' HD21 ' 1' ' 72' ' ' LEU . 1.4 t30 -55.36 -46.65 76.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.847 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.907 HG23 ' O ' ' 1' ' 35' ' ' LEU . 18.9 t -59.31 -48.6 86.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.843 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 3.3 tpt180 -48.8 -48.02 41.71 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.519 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . 0.908 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -58.41 -49.62 76.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.418 179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.437 ' O ' HG12 ' 1' ' 46' ' ' ILE . 0.1 OUTLIER -62.46 -38.69 90.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.869 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.782 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 0.9 OUTLIER -57.16 -33.33 67.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.445 179.394 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.6 m -85.36 -20.64 29.61 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.961 179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.908 HG23 ' O ' ' 1' ' 41' ' ' ALA . 14.1 p -85.49 -21.15 28.78 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.126 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.722 HG13 HG13 ' 1' ' 61' ' ' VAL . 14.6 mm -50.35 161.51 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.259 0 CA-C-O 120.988 0.423 . . . . 0.0 111.279 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.536 ' C ' ' H ' ' 1' ' 49' ' ' ASP . 0.8 OUTLIER -62.87 1.41 0.41 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 115.789 -0.641 . . . . 0.0 112.381 179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.47 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.5 OUTLIER -59.68 9.61 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 112.604 0.594 . . . . 0.0 112.604 -179.393 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.536 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 10.7 p-10 -78.11 34.11 0.19 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.56 0.219 . . . . 0.0 111.107 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.458 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.7 OUTLIER 88.26 73.93 0.01 OUTLIER 'General case' 0 C--O 1.232 0.135 0 C-N-CA 123.017 0.527 . . . . 0.0 110.81 -179.365 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.486 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -139.09 -166.94 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.868 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.577 ' O ' HG23 ' 1' ' 52' ' ' THR . 8.9 t -100.31 104.75 31.93 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.548 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . 0.571 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 2.7 Cg_exo -75.93 117.06 4.58 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.606 2.204 . . . . 0.0 112.761 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -147.12 -178.15 6.06 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.531 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -29.0 2.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.955 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.69 -40.16 49.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.661 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.461 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.82 -46.23 88.93 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.43 -51.48 62.49 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 114.88 -1.054 . . . . 0.0 110.841 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.65 -45.2 81.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.131 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.41 -50.86 61.67 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.535 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.722 HG13 HG13 ' 1' ' 46' ' ' ILE . 4.3 t -66.02 -41.84 90.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.182 179.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -58.66 -39.65 81.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.353 179.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -72.86 -49.14 31.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.625 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -57.77 -50.55 72.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.643 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.564 HG13 HG13 ' 1' ' 39' ' ' VAL . 0.3 OUTLIER -55.84 -53.66 35.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 N-CA-C 109.337 -0.616 . . . . 0.0 109.337 178.897 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.439 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 28.4 ttt180 -56.99 -32.9 66.59 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.591 179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . 0.523 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -63.9 -60.57 3.11 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.523 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.05 -40.11 96.81 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.949 -0.861 . . . . 0.0 110.949 178.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.857 HD21 ' CG2' ' 1' ' 39' ' ' VAL . 7.4 mt -61.41 -39.17 89.75 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-O 121.193 0.521 . . . . 0.0 109.897 179.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 24.9 tttt -68.24 -20.65 64.82 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.025 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -93.52 -4.56 50.83 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.356 0.502 . . . . 0.0 112.356 -179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.796 HD12 ' HA ' ' 1' ' 69' ' ' LEU . 0.3 OUTLIER -112.43 14.59 20.34 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 121.082 -0.247 . . . . 0.0 111.579 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . 0.603 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 124.86 -12.77 7.7 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.135 -1.031 . . . . 0.0 114.085 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.781 ' CE2' HD12 ' 1' ' 35' ' ' LEU . 6.9 m-30 -96.21 171.58 8.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 117.45 0.625 . . . . 0.0 111.235 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -123.54 -63.43 1.23 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.743 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.48 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 40.0 mt-30 -139.73 54.42 5.64 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 120.762 0.315 . . . . 0.0 111.386 179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.567 ' HG3' ' HB3' ' 1' ' 74' ' ' TYR . 75.4 Cg_exo -49.34 137.81 30.78 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.686 2.257 . . . . 0.0 113.184 179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 3.2 m -78.89 103.36 8.78 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.867 HG13 HG23 ' 1' ' 98' ' ' VAL . 4.9 mt -111.26 123.28 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.121 0.486 . . . . 0.0 112.125 -178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -116.05 177.19 4.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.519 -0.764 . . . . 0.0 110.042 179.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.915 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 66.2 m-85 -150.3 150.05 30.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.056 0.455 . . . . 0.0 111.807 -179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -133.95 94.83 3.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.214 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.726 HD11 ' OE1' ' 1' ' 92' ' ' GLN . 40.0 tp -79.77 149.04 31.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.715 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.58 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -148.25 101.0 3.58 Favored Pre-proline 0 C--O 1.239 0.514 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.22 179.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.561 ' HA ' ' HG2' ' 1' ' 92' ' ' GLN . 74.5 Cg_exo -51.01 -34.68 47.53 Favored 'Trans proline' 0 CA--C 1.532 0.376 0 C-N-CA 122.661 2.241 . . . . 0.0 113.097 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.554 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 98.6 Cg_endo -102.61 71.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 123.394 2.73 . . . . 0.0 113.261 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.456 ' HG3' ' N ' ' 1' ' 92' ' ' GLN . 32.7 Cg_endo -63.21 175.7 2.43 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.347 2.031 . . . . 0.0 112.133 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.406 ' HD3' ' N ' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -96.67 -28.14 14.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.92 -179.515 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.406 ' N ' ' HD3' ' 1' ' 88' ' ' LYS . 0.1 OUTLIER -129.73 32.26 4.62 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . . . . . . . . . . . -168.78 -155.15 9.44 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 119.801 -1.19 . . . . 0.0 113.095 179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.409 ' HB2' ' HB2' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -103.03 -45.12 5.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.933 0.397 . . . . 0.0 110.662 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.726 ' OE1' HD11 ' 1' ' 83' ' ' LEU . 0.0 OUTLIER -147.39 127.5 13.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.58 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 2.9 p -127.74 143.14 41.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.206 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.175 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.915 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.1 tm? -134.14 117.35 16.46 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.602 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.602 ' N ' HD22 ' 1' ' 94' ' ' LEU . 4.7 mt -79.76 147.62 6.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.613 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . . . . . . . . . . . -132.14 106.73 8.16 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.135 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 30.4 mtmt -107.45 148.93 28.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.559 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG11 HD21 ' 1' ' 31' ' ' LEU . 12.5 p -138.62 150.69 23.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.8 0.333 . . . . 0.0 111.459 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 66.2 m -156.34 90.65 2.66 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.97 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.528 ' HG3' ' CD2' ' 1' ' 74' ' ' TYR . 7.4 Cg_endo -86.96 -80.04 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.116 2.544 . . . . 0.0 112.057 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 150.57 -57.99 0.44 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.091 -1.052 . . . . 0.0 113.6 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 6.0 p -110.19 147.03 14.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.755 HD12 ' N ' ' 1' ' 104' ' ' GLU . 0.2 OUTLIER -141.04 114.17 8.56 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.509 179.128 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . 0.755 ' N ' HD12 ' 1' ' 103' ' ' LEU . 33.2 mt-10 -100.32 129.2 46.28 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.91 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 18.9 p80 -78.6 168.6 19.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.917 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -165.19 100.06 0.74 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -95.64 120.74 36.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.866 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.66 35.7 3.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.906 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 17.0 t-80 -132.85 161.15 34.93 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.88 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 59.0 m-70 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.226 -0.892 . . . . 0.0 110.869 179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . 0.428 ' HB3' ' HG3' ' 1' ' 91' ' ' ARG . . . . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 120.786 0.326 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.442 ' HB2' ' HG2' ' 1' ' 91' ' ' ARG . 0.4 OUTLIER -153.88 85.74 1.17 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.863 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.445 HG12 ' O ' ' 1' ' 92' ' ' GLN . 30.0 m -150.86 148.2 15.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.062 0.458 . . . . 0.0 111.274 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.09 126.91 11.81 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.757 -179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.769 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 0.0 OUTLIER -75.79 114.97 15.0 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.958 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . 0.516 ' HB3' HG23 ' 1' ' 95' ' ' ILE . 2.6 mt-30 -80.52 112.56 17.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.638 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 1.031 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.6 OUTLIER -84.09 137.5 20.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.445 -179.785 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.567 ' O ' HG12 ' 1' ' 98' ' ' VAL . 3.0 mt-10 -148.54 122.97 9.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.969 179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . 0.456 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 97.4 43.8 2.89 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.847 179.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.706 HD21 HG11 ' 1' ' 98' ' ' VAL . 16.1 mt -140.7 148.81 41.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.765 0.316 . . . . 0.0 110.736 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.53 133.42 20.17 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.009 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . 0.437 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . . . 66.01 -141.1 41.01 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.734 -0.745 . . . . 0.0 112.483 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.66 -26.79 3.97 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.707 0.289 . . . . 0.0 111.369 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.7 ' HA ' HD13 ' 1' ' 72' ' ' LEU . 0.6 OUTLIER -64.48 -54.07 38.26 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.918 0.39 . . . . 0.0 110.682 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.53 -37.58 84.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.99 179.357 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' 1' ' 33' ' ' GLY . 3.1 mtmm -65.86 -48.04 72.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.544 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.718 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 1.0 OUTLIER -54.96 -54.36 43.83 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.609 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.578 HG21 ' CD1' ' 1' ' 31' ' ' LEU . 56.1 t -56.09 -34.67 39.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.435 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -57.67 -47.47 82.21 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.037 0.446 . . . . 0.0 109.879 179.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . . . . . . . . . . . -58.75 -41.02 85.54 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.549 ' HA ' HG22 ' 1' ' 45' ' ' THR . 0.5 OUTLIER -67.25 -36.82 82.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.741 178.826 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 1.031 HD11 HG13 ' 1' ' 28' ' ' VAL . 2.7 mt -57.27 -36.41 70.99 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.565 179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 2.1 m -79.26 -31.56 43.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.118 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.549 HG22 ' HA ' ' 1' ' 42' ' ' GLN . 1.1 t -83.11 -8.67 59.49 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 -179.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.715 HG23 HG22 ' 1' ' 61' ' ' VAL . 9.8 mt -54.75 161.41 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.193 0 CA-C-O 120.854 0.359 . . . . 0.0 111.089 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.553 ' N ' HG22 ' 1' ' 46' ' ' ILE . 1.9 mm-40 -71.24 0.67 7.38 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.717 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.427 ' C ' ' H ' ' 1' ' 50' ' ' GLU . 0.3 OUTLIER -63.66 9.79 0.06 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.514 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.467 ' H ' ' C ' ' 1' ' 47' ' ' GLU . 3.3 m-20 -74.86 34.04 0.1 Allowed 'General case' 0 CA--C 1.531 0.225 0 O-C-N 122.395 -0.19 . . . . 0.0 111.352 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.466 ' CB ' ' O ' ' 1' ' 49' ' ' ASP . 0.9 OUTLIER 88.01 69.71 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 121.116 0.484 . . . . 0.0 110.752 -179.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . . . . . . . . . 6.2 m -134.14 -167.01 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.816 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . 0.569 ' O ' HG23 ' 1' ' 52' ' ' THR . 9.9 t -106.18 101.51 34.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.72 179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.34 117.13 3.99 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.434 2.089 . . . . 0.0 112.58 -179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -147.17 -178.11 6.04 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.613 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -47.32 -28.87 2.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.011 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.23 -45.51 26.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.86 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.663 ' O ' HG23 ' 1' ' 61' ' ' VAL . 4.5 t80 -59.09 -46.98 86.91 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . 0.43 ' HG2' ' CD2' ' 1' ' 81' ' ' PHE . 2.5 ttp180 -57.12 -39.36 74.98 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.952 179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.54 -41.77 68.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -55.83 -47.43 77.24 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.346 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.928 ' O ' HD12 ' 1' ' 65' ' ' ILE . 9.4 t -64.04 -48.12 87.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.201 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.68 -48.06 66.78 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.449 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -61.27 -46.01 92.14 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.381 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . . . . . . . . . . . -51.48 -61.15 2.43 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.913 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 0.928 HD12 ' O ' ' 1' ' 61' ' ' VAL . 2.9 mp -47.92 -58.98 0.85 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 CA-C-O 120.909 0.385 . . . . 0.0 110.337 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.42 ' O ' ' CB ' ' 1' ' 70' ' ' LYS . 27.6 ttt-85 -53.4 -30.67 41.32 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.598 179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . 0.516 ' CG ' ' N ' ' 1' ' 68' ' ' GLY . 0.0 OUTLIER -65.0 -60.75 2.69 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 179.289 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.516 ' N ' ' CG ' ' 1' ' 67' ' ' GLU . . . -65.0 -42.42 96.8 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.703 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 8.8 mt -60.31 -32.78 71.54 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.072 0.463 . . . . 0.0 110.085 179.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.637 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 18.1 ttmt -72.49 -21.78 61.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.645 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -94.85 -4.5 46.93 Favored 'General case' 0 C--N 1.33 -0.283 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.718 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.2 OUTLIER -114.87 10.06 16.33 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -179.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . 0.512 ' HA3' HD13 ' 1' ' 103' ' ' LEU . . . 111.19 -10.96 28.99 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.328 -0.939 . . . . 0.0 113.095 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.706 ' HE1' HD22 ' 1' ' 103' ' ' LEU . 3.4 m-30 -97.05 99.88 11.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.887 0.375 . . . . 0.0 110.088 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -52.74 -85.72 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -178.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.4 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 0.3 OUTLIER -126.98 58.18 27.72 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -178.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.676 ' CG ' ' HB3' ' 1' ' 74' ' ' TYR . 82.3 Cg_exo -47.47 136.06 20.47 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.776 2.318 . . . . 0.0 112.96 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 7.3 m -70.48 103.32 2.43 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 178.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 0.871 HG13 HG23 ' 1' ' 98' ' ' VAL . 3.9 mt -113.51 113.37 43.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.122 0.487 . . . . 0.0 111.871 -178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -110.26 177.0 4.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.098 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.74 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 68.0 m-85 -141.54 156.38 45.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.22 0.533 . . . . 0.0 111.908 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . 0.643 ' HB3' HD12 ' 1' ' 95' ' ' ILE . 19.2 t0 -132.72 94.96 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.463 -0.789 . . . . 0.0 109.929 179.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.458 HD13 HD23 ' 1' ' 94' ' ' LEU . 2.4 tp -76.47 145.92 38.89 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.759 -0.655 . . . . 0.0 112.001 -178.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.46 ' N ' ' O ' ' 1' ' 93' ' ' VAL . 1.7 mpt_? -139.38 73.08 37.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.364 179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.489 ' N ' ' CD ' ' 1' ' 86' ' ' PRO . 3.8 Cg_exo -39.6 -40.46 2.23 Favored 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 123.064 2.509 . . . . 0.0 113.382 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' 1' ' 85' ' ' PRO . 72.5 Cg_endo -103.04 69.26 0.03 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.346 2.697 . . . . 0.0 113.522 -178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.467 ' HB3' HG23 ' 1' ' 93' ' ' VAL . 36.2 Cg_endo -65.26 177.28 2.66 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.184 1.923 . . . . 0.0 112.212 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.3 -33.46 11.96 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.3 32.2 4.5 Favored 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 112.381 0.512 . . . . 0.0 112.381 -178.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.413 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -162.84 -156.03 8.34 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.618 -1.277 . . . . 0.0 113.244 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.442 ' HG2' ' HB2' ' 1' ' 23' ' ' ASN . 21.9 mmm180 -99.08 -52.57 3.5 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.949 0.404 . . . . 0.0 110.215 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . 0.445 ' O ' HG12 ' 1' ' 24' ' ' VAL . 7.9 mt-30 -147.74 127.05 13.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.532 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' 1' ' 87' ' ' PRO . 1.3 t -96.92 128.89 47.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.718 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 2.2 tm? -132.29 116.71 17.25 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.028 0.442 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.643 HD12 ' HB3' ' 1' ' 82' ' ' ASP . 3.5 mt -96.39 152.98 3.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.21 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.513 ' HB2' HD11 ' 1' ' 26' ' ' LEU . . . -133.14 108.06 8.58 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.174 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.95 121.44 45.13 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.738 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.871 HG23 HG13 ' 1' ' 79' ' ' ILE . 10.2 p -112.25 146.91 16.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.366 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 64.4 m -154.66 91.0 3.05 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.008 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.589 ' HB3' ' HG3' ' 1' ' 77' ' ' PRO . 12.1 Cg_endo -88.92 -80.56 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.096 2.531 . . . . 0.0 112.512 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 120.48 -22.76 8.21 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.568 -0.825 . . . . 0.0 113.206 179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . . . . . . . . . 7.2 p -115.82 144.82 22.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.026 0.441 . . . . 0.0 112.082 -179.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.706 HD22 ' HE1' ' 1' ' 74' ' ' TYR . 0.2 OUTLIER -141.01 107.23 5.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.156 178.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . 0.608 ' N ' HD12 ' 1' ' 103' ' ' LEU . 1.9 pm0 -87.29 142.14 28.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.059 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 65.09 -165.27 0.24 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.87 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 11.4 t60 67.42 108.19 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.93 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -59.72 144.24 48.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.983 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 3.4 t-80 -176.85 37.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -170.09 177.56 4.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.87 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 7.3 m170 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.231 -0.89 . . . . 0.0 110.881 179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' 1' 1 ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.325 0 CA-C-O 120.815 0.341 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' 1' 1 ' 23' ' ' ASN . . . . . 0.415 ' CB ' ' CD ' ' 1' ' 91' ' ' ARG . 9.8 m-80 -147.85 80.11 1.48 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 24' ' ' VAL . . . . . 0.77 HG21 ' O ' ' 1' ' 48' ' ' SER . 35.1 m -150.16 149.99 14.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.202 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 25' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -149.42 108.17 3.85 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.76 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 26' ' ' LEU . . . . . 0.899 ' HB3' HD13 ' 1' ' 43' ' ' LEU . 4.0 mp -68.26 133.03 48.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.882 0.372 . . . . 0.0 110.766 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 27' ' ' GLN . . . . . 0.608 ' O ' ' HB3' ' 1' ' 96' ' ' ALA . 0.5 OUTLIER -87.3 139.48 30.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.01 -179.76 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 28' ' ' VAL . . . . . 0.892 HG13 HD11 ' 1' ' 43' ' ' LEU . 0.1 OUTLIER -108.35 137.77 38.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.314 -179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 29' ' ' GLU . . . . . 0.856 ' O ' HG12 ' 1' ' 98' ' ' VAL . 0.5 OUTLIER -147.03 133.06 19.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.632 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 30' ' ' GLY . . . . . 0.466 ' O ' HG13 ' 1' ' 98' ' ' VAL . . . 82.5 39.57 10.75 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.409 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 31' ' ' LEU . . . . . 0.804 HD21 HG11 ' 1' ' 98' ' ' VAL . 12.0 mt -139.85 157.64 45.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.0 110.71 -179.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 32' ' ' SER . . . . . 0.403 ' H ' ' HB2' ' 1' ' 35' ' ' LEU . 2.3 m -165.43 157.0 14.57 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.068 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 33' ' ' GLY . . . . . . . . . . . . . . . 58.22 -112.38 3.88 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.897 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 34' ' ' GLN . . . . . 0.5 ' O ' ' HG3' ' 1' ' 37' ' ' LYS . 0.0 OUTLIER -89.25 -9.85 49.14 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.741 0.275 . . . . 0.0 111.741 -179.475 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 35' ' ' LEU . . . . . 0.726 ' O ' HG23 ' 1' ' 39' ' ' VAL . 1.1 mm? -80.31 -47.78 14.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.045 0.45 . . . . 0.0 110.16 179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 36' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -67.41 -29.03 68.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.498 179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 37' ' ' LYS . . . . . 0.5 ' HG3' ' O ' ' 1' ' 34' ' ' GLN . 0.0 OUTLIER -76.08 -43.8 41.81 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.507 179.671 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 38' ' ' ASN . . . . . 0.685 ' CB ' HD11 ' 1' ' 72' ' ' LEU . 0.8 OUTLIER -61.81 -45.56 93.32 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.159 179.489 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 39' ' ' VAL . . . . . 0.726 HG23 ' O ' ' 1' ' 35' ' ' LEU . 48.7 t -61.91 -44.49 98.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.324 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 40' ' ' ARG . . . . . . . . . . . . . 13.6 mtp180 -51.16 -45.52 61.75 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.31 179.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 41' ' ' ALA . . . . . 0.935 ' O ' HG23 ' 1' ' 45' ' ' THR . . . -60.92 -51.75 67.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.304 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 42' ' ' GLN . . . . . 0.453 ' HB3' ' HB1' ' 1' ' 64' ' ' ALA . 3.4 mt-30 -61.59 -32.48 72.59 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.168 179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 43' ' ' LEU . . . . . 0.899 HD13 ' HB3' ' 1' ' 26' ' ' LEU . 1.0 OUTLIER -59.93 -40.43 88.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.132 179.187 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 44' ' ' SER . . . . . . . . . . . . . 1.5 m -80.97 -17.86 48.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.261 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 45' ' ' THR . . . . . 0.935 HG23 ' O ' ' 1' ' 41' ' ' ALA . 15.9 p -86.5 -20.52 27.94 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.788 0.327 . . . . 0.0 111.18 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 46' ' ' ILE . . . . . 0.861 HG13 HG13 ' 1' ' 61' ' ' VAL . 3.0 mm -55.35 161.5 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.041 0.448 . . . . 0.0 111.226 -179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 47' ' ' GLU . . . . . 0.537 ' O ' HG13 ' 1' ' 51' ' ' VAL . 28.9 mt-10 -67.34 1.2 2.33 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.844 -0.616 . . . . 0.0 112.555 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 48' ' ' SER . . . . . 0.77 ' O ' HG21 ' 1' ' 24' ' ' VAL . 0.9 OUTLIER -55.82 -2.06 0.05 Allowed 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 112.401 0.519 . . . . 0.0 112.401 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 49' ' ' ASP . . . . . 0.457 ' O ' ' CB ' ' 1' ' 50' ' ' GLU . 9.6 p-10 -68.34 34.16 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 111.967 0.358 . . . . 0.0 111.967 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 50' ' ' GLU . . . . . 0.502 ' H ' ' C ' ' 1' ' 48' ' ' SER . 0.0 OUTLIER 88.0 75.37 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 122.826 0.451 . . . . 0.0 110.931 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 51' ' ' VAL . . . . . 0.537 HG13 ' O ' ' 1' ' 47' ' ' GLU . 4.2 m -141.07 -166.85 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.035 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 52' ' ' THR . . . . . . . . . . . . . 98.4 m -99.49 96.84 4.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.555 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 53' ' ' PRO . . . . . 0.413 ' HB2' HD22 ' 1' ' 83' ' ' LEU . 57.4 Cg_endo -70.99 117.08 4.97 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.377 2.052 . . . . 0.0 112.779 -179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 54' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -147.13 -177.75 5.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.342 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 55' ' ' ARG . . . . . . . . . . . . . 8.7 ttt85 -44.8 -29.06 0.72 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.811 0.339 . . . . 0.0 111.154 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 56' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -77.51 -39.81 44.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.701 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 57' ' ' PHE . . . . . 0.589 ' O ' HG23 ' 1' ' 61' ' ' VAL . 5.8 t80 -62.98 -44.75 95.17 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 108.914 -0.772 . . . . 0.0 108.914 178.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 58' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -54.28 -48.02 71.71 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.23 -45.34 87.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.118 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 60' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -54.87 -50.44 68.68 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.674 179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 61' ' ' VAL . . . . . 0.861 HG13 HG13 ' 1' ' 46' ' ' ILE . 2.4 t -64.94 -39.4 85.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.121 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 62' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -62.7 -51.0 68.92 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.34 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -61.09 -44.84 96.75 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.546 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 64' ' ' ALA . . . . . 0.453 ' HB1' ' HB3' ' 1' ' 42' ' ' GLN . . . -55.22 -51.03 67.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.615 179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 65' ' ' ILE . . . . . 1.003 HD13 HG21 ' 1' ' 79' ' ' ILE . 7.4 mt -58.85 -57.85 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.53 179.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 66' ' ' ARG . . . . . 0.433 ' O ' ' N ' ' 1' ' 70' ' ' LYS . 40.0 ttm180 -54.76 -37.84 66.47 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.956 -0.566 . . . . 0.0 111.11 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 67' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -61.75 -59.49 5.08 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 68' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' 1' ' 72' ' ' LEU . . . -64.61 -37.0 93.83 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.373 -0.918 . . . . 0.0 111.044 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 69' ' ' LEU . . . . . 0.685 ' HA ' HD12 ' 1' ' 72' ' ' LEU . 4.8 mt -66.48 -31.95 73.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.074 0.464 . . . . 0.0 110.064 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 70' ' ' LYS . . . . . 0.737 ' HA ' ' O ' ' 1' ' 74' ' ' TYR . 13.0 ttmt -70.13 -24.94 63.26 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.574 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 71' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.07 -0.513 . . . . 0.0 112.361 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 72' ' ' LEU . . . . . 0.685 HD11 ' CB ' ' 1' ' 38' ' ' ASN . 0.8 OUTLIER -112.07 8.38 20.05 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.148 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 73' ' ' GLY . . . . . . . . . . . . . . . 125.02 4.03 7.32 Favored Glycine 0 CA--C 1.517 0.197 0 C-N-CA 120.023 -1.084 . . . . 0.0 114.469 178.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 74' ' ' TYR . . . . . 0.795 ' CZ ' HD13 ' 1' ' 103' ' ' LEU . 24.1 m-85 -117.19 171.37 7.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 117.863 0.832 . . . . 0.0 111.708 -179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 75' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -121.29 -50.39 2.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.786 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 76' ' ' GLN . . . . . 0.454 ' N ' ' HD3' ' 1' ' 77' ' ' PRO . 7.8 pt20 -152.89 54.66 1.25 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.523 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 77' ' ' PRO . . . . . 0.573 ' HG3' ' HB3' ' 1' ' 100' ' ' PRO . 73.0 Cg_exo -49.15 127.73 18.12 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.329 2.019 . . . . 0.0 112.357 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 78' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -63.66 103.18 0.52 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 79' ' ' ILE . . . . . 1.003 HG21 HD13 ' 1' ' 65' ' ' ILE . 4.5 mt -113.43 106.25 20.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 121.118 0.485 . . . . 0.0 111.739 -178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 80' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -97.78 173.72 6.97 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.372 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 81' ' ' PHE . . . . . 0.834 ' HB3' HD21 ' 1' ' 94' ' ' LEU . 79.1 m-85 -143.8 156.86 44.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.149 0.5 . . . . 0.0 111.965 -179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 82' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -145.85 94.59 2.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.835 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 83' ' ' LEU . . . . . 0.722 ' HB2' HD23 ' 1' ' 94' ' ' LEU . 3.6 tp -91.09 140.32 29.93 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.671 -178.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 84' ' ' ARG . . . . . 0.857 ' HG2' HG12 ' 1' ' 93' ' ' VAL . 0.0 OUTLIER -140.21 109.72 6.96 Favored Pre-proline 0 C--O 1.237 0.396 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.882 179.077 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 85' ' ' PRO . . . . . 0.563 ' CD ' ' HD3' ' 1' ' 86' ' ' PRO . 14.8 Cg_endo -58.89 -26.05 79.34 Favored 'Trans proline' 0 CA--C 1.535 0.554 0 C-N-CA 122.818 2.346 . . . . 0.0 114.552 -178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 86' ' ' PRO . . . . . 0.563 ' HD3' ' CD ' ' 1' ' 85' ' ' PRO . 92.9 Cg_endo -101.95 67.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.752 2.301 . . . . 0.0 113.521 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 87' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' 1' ' 85' ' ' PRO . 33.1 Cg_endo -64.55 177.3 2.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.365 2.043 . . . . 0.0 112.081 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 88' ' ' LYS . . . . . 0.415 ' HD2' ' HB2' ' 1' ' 89' ' ' LYS . 0.0 OUTLIER -95.22 -32.79 12.86 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.936 -0.574 . . . . 0.0 112.01 -179.616 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 89' ' ' LYS . . . . . 0.415 ' HB2' ' HD2' ' 1' ' 88' ' ' LYS . 0.5 OUTLIER -130.24 32.27 4.5 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 90' ' ' GLY . . . . . 0.443 ' O ' ' HG2' ' 1' ' 87' ' ' PRO . . . -164.88 -158.07 10.12 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 119.517 -1.325 . . . . 0.0 113.288 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 91' ' ' ARG . . . . . 0.415 ' CD ' ' CB ' ' 1' ' 23' ' ' ASN . 0.0 OUTLIER -95.1 -55.83 2.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.913 0.387 . . . . 0.0 110.366 179.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 92' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 -147.71 141.62 25.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.904 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 93' ' ' VAL . . . . . 0.857 HG12 ' HG2' ' 1' ' 84' ' ' ARG . 0.8 OUTLIER -127.65 150.46 33.49 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 C-N-CA 120.477 -0.489 . . . . 0.0 111.98 -179.644 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 94' ' ' LEU . . . . . 0.834 HD21 ' HB3' ' 1' ' 81' ' ' PHE . 1.4 tm? -135.81 115.88 13.31 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.759 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 95' ' ' ILE . . . . . 0.693 HD11 ' CZ ' ' 1' ' 84' ' ' ARG . 5.0 mt -81.99 152.86 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.201 -179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 96' ' ' ALA . . . . . 0.608 ' HB3' ' O ' ' 1' ' 27' ' ' GLN . . . -142.72 107.5 4.87 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.197 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 97' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' 1' ' 79' ' ' ILE . 0.3 OUTLIER -109.48 123.02 48.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.644 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' 1' 1 ' 98' ' ' VAL . . . . . 0.886 HG23 HG13 ' 1' ' 79' ' ' ILE . 11.8 p -110.6 148.19 14.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.549 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 99' ' ' THR . . . . . . . . . . . . . 58.4 m -157.47 89.91 2.43 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.94 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 100' ' ' PRO . . . . . 0.653 ' HG2' ' CE1' ' 1' ' 74' ' ' TYR . 18.3 Cg_endo -87.69 -84.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.951 2.434 . . . . 0.0 112.65 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 101' ' ' GLY . . . . . . . . . . . . . . . 161.34 -65.83 0.26 Allowed Glycine 0 C--N 1.334 0.436 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.086 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 102' ' ' VAL . . . . . 0.416 ' O ' ' CD1' ' 1' ' 74' ' ' TYR . 4.6 p -115.47 153.53 17.0 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-O 120.865 0.364 . . . . 0.0 111.829 -179.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 103' ' ' LEU . . . . . 0.795 HD13 ' CZ ' ' 1' ' 74' ' ' TYR . 4.9 tp -140.7 144.73 35.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 104' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -70.48 142.15 51.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.883 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -106.42 153.84 21.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.908 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 106' ' ' HIS . . . . . . . . . . . . . 1.2 t-160 -66.31 -169.61 0.07 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.903 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 107' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -168.65 151.25 5.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.893 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' 1' 1 ' 108' ' ' HIS . . . . . . . . . . . . . 18.5 m80 -102.86 -48.99 3.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.94 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 109' ' ' HIS . . . . . . . . . . . . . 56.3 p-80 -60.78 164.32 4.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.959 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' 1' 1 ' 110' ' ' HIS . . . . . . . . . . . . . 2.9 t60 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.894 -179.979 . . . . . . . . 0 0 . 1 stop_ save_